Patent Grant
10993824
Disclosed herein are delivery devices and methods of delivery. Certain embodiments are described with reference to sequential delivery of multiple intraluminal devices from a delivery device. The delivery devices and methods can be used in procedures to treat atherosclerotic occlusive disease, though they are not limited to these procedures.
There are a number of medical conditions and procedures in which a device such as a stent is placed in the body to create or maintain a passage. There are a wide variety of stents used for different purposes, from expandable coronary, vascular and biliary stents, to plastic stents used to allow the flow of urine between kidney and bladder.
Stents are often placed in the vascular system after a medical procedure, such as balloon angioplasty. Balloon angioplasty is often used to treat atherosclerotic occlusive disease. Atherosclerotic occlusive disease is the primary cause of stroke, heart attack, limb loss, and death in the US and the industrialized world. Atherosclerotic plaque forms a hard layer along the wall of an artery and can be comprised of calcium, cholesterol, compacted thrombus and cellular debris. As the atherosclerotic disease progresses, the blood supply intended to pass through a specific blood vessel is diminished or even prevented by the occlusive process. One of the most widely utilized methods of treating clinically significant atherosclerotic plaque is balloon angioplasty, which may be followed with stent placement.
Currently available stents and stent delivery systems have many limitations and drawbacks. There exists a continuing need for improvement in intraluminal devices and associated delivery devices.
According to certain embodiments, a delivery device can be provided for sequential delivery of a plurality of intraluminal devices (e.g., stents, tacks, staples, etc.) held in a compressed state on the delivery device. For purposes of this disclosure the word tack will be used to describe one of many intraluminal devices which can be deployed from a delivery device. The delivery device can comprise a plurality of delivery platforms, the delivery platforms configured for holding a tack in a compressed position on the delivery device and having a unique shape, such as a non-constant outer diameter, an hourglass shape, a tapered proximal half, ridges, dimples, etc. This unique shape can be positioned between annular pusher bands that may also be radiopaque markers.
In some embodiments, the unique shape is provided by a sleeve of flexible material with the unique shape surrounding a harder inner shaft. Further, the annular pusher bands can be made of wire or sections of material to increase flexibility while remaining radiopacity.
A tack deployment method can include alignment of radiopaque markers on the outer sheath and the tack to be deployed prior to deployment.
A method of marker band alignment and intraluminal device or tack delivery can be performed. The method can include: advancing a delivery device with a plurality of tacks in a compressed state to a treatment area; each tack comprising a plurality of struts and a radiopaque marker positioned in a central region of the tack, each tack being a same size with the radiopaque marker positioned in a same location; the delivery device comprising an inner core having a plurality of delivery platforms, each delivery platform having one of the plurality of tacks, and an outer sheath covering the inner core and the delivery platforms, the outer sheath having a radiopaque marker band positioned proximally from a distal end; withdrawing the outer sheath until the radiopaque marker band on the outer sheath and radiopaque marker on a first tack to be delivered are aligned; aligning these two radiopaque markers with a treatment area such as a tissue dissection or lesion to be treated before release of the tack; then withdrawing the outer sheath to release the tack.
In some embodiments, a delivery device can comprise an inner shaft, a delivery platform and an outer sheath. The delivery platform can include a pair of annular bands around the inner shaft, both of the annular bands having a first outer diameter and a sleeve. The sleeve can be secured to the inner shaft and positioned between the annular bands. The sleeve can have a lower durometer than the inner shaft and optimally also lower than the pair of annular bands. The sleeve can further have a non-constant outer diameter being less than the first outer diameter of the annular bands. The delivery platform can be configured to receive an intraluminal device for deployment from the delivery device into a vessel and to receive the intraluminal device between the annular bands and on the sleeve. The outer sheath can be positioned on and slidable over the inner shaft and the delivery platform, the outer sheath having a pre-deployment position covering the delivery platform and at least one delivery position where the outer sheath is withdrawn exposing at least one of the annular bands and the sleeve of the delivery platform.
According to some embodiments, a plurality of additional delivery platforms can be included for sequential delivery of a plurality of intraluminal devices. Each additional delivery platform can comprise an additional sleeve and an additional annular band. Each of the annular bands can have a radius on a proximal end and/or comprise a radiopaque helical coil. The radiopaque helical coil can be encased in a polymer having a higher durometer than a polymer that forms the sleeve.
The sleeve can include any number of different shapes and sizes, and can include ridges, dots, dimples, etc.
In some embodiments, a delivery device can comprise an inner shaft, the inner shaft having a nose cone on the distal tip; a delivery platform; and an outer sheath. The delivery platform can comprise a pair of annular bands secured to the inner shaft, both of the annular bands having a first outer diameter; and a sleeve secured to the inner shaft and positioned between the annular bands. The sleeve can have a lower durometer than the inner shaft and optionally also the pair of annular bands. The sleeve may further have a first constant outer diameter section and a second constant outer diameter section having a larger outer diameter than the first, but less than the first outer diameter of the annular bands, and the second constant outer diameter section having a shorter axial length than the first constant outer diameter section, the sleeve further having a smooth tapered transition between the first and second constant outer diameter sections. The delivery platform can be configured to receive an intraluminal device for deployment from the delivery device into a vessel and configured to receive the intraluminal device between the annular bands and on the sleeve. The outer sheath can be positioned on and slidable over the inner shaft and the delivery platform. The outer sheath can have a pre-deployment position covering the delivery platform and at least one delivery position where the outer sheath is withdrawn exposing at least one of the annular bands and the sleeve of the delivery platform.
In some embodiments, a delivery device can comprise an inner shaft, a distal annular band, a proximal annular band, a delivery platform, an outer sheath, and a post dilation deployment device. The distal annular band and the proximal annular band can be surrounding and fixed to the inner shaft. The inner shaft can have a first diameter and the distal annular band and the proximal annular band can have a second diameter that is larger than the first diameter (of the inner shaft). The delivery platform can be defined by a proximal end of the distal annular band and a distal end of the proximal annular band. The delivery platform can be configured to receive a self-expanding intraluminal device between the distal annular band and the proximal annular band and around the inner shaft for deployment from the delivery device into a vessel. The outer sheath can be positioned on and slidable over the inner shaft and the delivery platform. The outer sheath can have a pre-deployment position, covering the delivery platform, and at least one delivery position, where the outer sheath is withdrawn exposing the delivery platform and at least one of the distal annular band and the proximal annular band. The post dilation deployment device can comprise a deployment platform and a plurality of expansion filaments. The deployment platform can be fixed with respect to the inner shaft. The plurality of expansion filaments can be radially spaced around the inner shaft. Further, each expansion filament of the plurality of expansion filaments can have a first end fixed with respect to an end of the deployment platform. The plurality of expansion filaments can have a pre-actuated position, having a pre-deployment diameter, and an actuated position, having a deployment diameter larger than the pre-deployment diameter. The post dilation deployment device can be configured to apply a radial force to an inner surface of the self-expanding intraluminal device after deployment of the self-expanding intraluminal device so as to improve at least one of expansion of the self-expanding intraluminal device and seating of the self-expanding intraluminal device in the vessel.
A delivery device can comprise an inner shaft, a delivery platform, an outer sheath, and a post dilation deployment device. The inner shaft can have a nose cone on the distal tip. The delivery platform can be fixed in position on the inner shaft with respect to the nose cone. Furthermore, the delivery platform can comprise a pair of annular bands secured to the inner shaft and a middle portion. Both of the annular bands can have a first outer diameter and the middle portion can have a second outer diameter. The second diameter can be smaller than the first outer diameter. The delivery platform can be configured to receive an intraluminal device for deployment from the delivery device into a vessel. More specifically, the delivery platform can be configured to receive the intraluminal device between the annular bands and on the inner shaft. The outer sheath can be positioned on and slidable over the inner shaft and the delivery platform. The outer sheath can have a pre-deployment position, covering the delivery platform, and at least one delivery position, where the outer sheath is withdrawn exposing at least one of the annular bands and the sleeve of the delivery platform. The post dilation deployment device can be positioned between the nose cone and the delivery platform and can comprise a plurality of expansion filaments. The expansion filaments can be configured to be radially expanded upon actuation so as to generate an outward radial force on an inner surface of the intraluminal device after release of the intraluminal device.
An intraluminal device deployment method can include one or more of the following steps. Advancing a delivery device with a plurality of intraluminal devices in a compressed state to a treatment area. Each of the plurality of intraluminal devices can comprise a plurality of struts and a radiopaque marker positioned in a central region of the intraluminal device. Each of the plurality of intraluminal devices can be a same size with the radiopaque marker positioned in a same location. The delivery device can comprise an inner shaft having a plurality of delivery platforms, each intraluminal device of the plurality of intraluminal devices positioned at a respective delivery platform of the plurality of delivery platforms, and an outer sheath covering the inner shaft and the plurality of delivery platforms, the outer sheath having a radiopaque marker band positioned proximally from a distal end of the outer sheath. Withdrawing the outer sheath until the radiopaque marker band on the outer sheath and radiopaque marker on a first intraluminal device to be delivered of the plurality of intraluminal devices are aligned. Aligning the aligned radiopaque marker band and the radiopaque marker with the treatment area before release of the first intraluminal device. Withdrawing the outer sheath to release the first intraluminal device. Withdrawing the outer sheath until the radiopaque marker band on the outer sheath and radiopaque marker on a second intraluminal device to be delivered of the plurality of intraluminal devices are aligned.
In some embodiments of the method, aligning the aligned radiopaque marker band and the radiopaque marker with the treatment area can comprise centering the aligned radiopaque marker band and the radiopaque marker at a tissue dissection before release of the first intraluminal device. In some embodiments of the method, withdrawing the outer sheath until the radiopaque marker band on the outer sheath and radiopaque marker on the first intraluminal device to be delivered of the plurality of intraluminal devices are aligned can comprise withdrawing the outer sheath until a distal-most end of the outer sheath and a distal-most end of the first intraluminal device are aligned. In some embodiments of the method, withdrawing the outer sheath until the radiopaque marker band on the outer sheath and radiopaque marker on the first intraluminal device to be delivered of the plurality of intraluminal devices are aligned can comprise withdrawing the outer sheath until the radiopaque marker band is positioned at a middle of the first intraluminal device. In some embodiments of the method, the first intraluminal device can have a single column of radiopaque markers and withdrawing the outer sheath until the radiopaque marker band on the outer sheath and radiopaque marker on the first intraluminal device to be delivered of the plurality of intraluminal devices are aligned can comprise withdrawing the outer sheath until the radiopaque marker band encircles the single column of radiopaque markers.
An intraluminal device deployment method can comprise advancing a delivery device with an intraluminal device in a compressed state to a target volume. The delivery device can comprise an inner shaft, a delivery platform, an outer sheath and a post dilation deployment device. The inner shaft can have a first diameter. The delivery platform can have a distal and a proximal annular band each having a second diameter larger than the first diameter (of the inner shaft). The delivery platform can be configured to receive the intraluminal device between the annular bands and around the inner shaft for deployment from the delivery device into a volume. The outer sheath can be positioned about and slidable over the inner shaft and the delivery platform. The outer sheath can have a pre-deployment position, covering the delivery platform, and a deployment position, exposing the delivery platform. The post dilation deployment device can comprise a plurality of expansion filaments configured to be radially expanded upon activation of the post deployment dilation device so as to generate an outward radial force on an inner surface of the intraluminal device after release and expansion of the intraluminal device. The intraluminal device deployment method can further comprise: withdrawing the outer sheath to release the intraluminal device; expanding the intraluminal device; moving the delivery device so as to position at least a portion of the post deployment dilation device within the expanded intraluminal device; and activating the post deployment dilation device to cause at least a portion of the post deployment dilation device to radially expand and to generate an outward radial force on an inner surface of the expanded intraluminal device. The expanding step can comprise one of allowing the intraluminal device to expand and actively expanding the intraluminal device.
In some embodiments, a delivery device comprises an inner shaft, a distal annular band and a proximal annular band, a delivery platform, an outer sheath, and a post dilation deployment device. The distal annular band and the proximal annular band can be fixed to the inner shaft. The delivery platform can be between the distal annular band and the proximal annular band. The delivery platform can be configured to receive a self-expanding intraluminal device for deployment from the delivery device into a vessel. The outer sheath can be slidable over the inner shaft and the delivery platform. The outer sheath can have a pre-deployment position covering the delivery platform. The outer sheath can have at least one delivery position uncovering the delivery platform and at least one of the distal annular band and the proximal annular band. The post dilation deployment device can comprise a deployment platform, a balloon, and at least one inflation fluid lumen. The deployment platform can be fixed with respect to the inner shaft. The balloon can be fixed with respect to a longitudinal axis of the deployment platform. The balloon can have a pre-actuated position having a pre-deployment diameter and an actuated position having a deployment diameter larger than the pre-deployment diameter. The least one inflation fluid lumen can be in fluid communication with the balloon and extend along at least a portion of the inner shaft. The post dilation deployment device can be configured to apply a radial force to an inner surface of the self-expanding intraluminal device after deployment of the self-expanding intraluminal device to improve at least one of expansion of the self-expanding intraluminal device and seating of the self-expanding intraluminal device in the vessel. The at least one inflation lumen can be contained within a wall of the inner shaft. The delivery device can further comprise a tubular shaft surrounding at least a portion of a length of the inner shaft and create a space between the tubular shaft and at least a portion of the length of the inner shaft. An inner surface of the tubular shaft and an outer surface of the inner shaft can define the at least one inflation lumen. A proximal end of the balloon can be fixed to the tubular shaft and a distal end of the balloon can be fixed to the inner shaft.
Various embodiments are depicted in the accompanying drawings for illustrative purposes, and should in no way be interpreted as limiting the scope of the inventions, in which like reference characters denote corresponding features consistently throughout similar embodiments.
A delivery device 10 can be used as part of a procedure to treat atherosclerotic occlusive disease. The delivery device can be used to deliver one or more intraluminal devices 2, such as tacks, to a site of plaque accumulation. The tacks can stabilize the site and/or hold pieces of plaque out of the way of blood flow. It will be understood that though the delivery devices and methods described herein are described primarily with reference to vascular procedures, they can also be used in treatments for other parts of the body.
The delivery device 10 of
Relatively small intraluminal devices 2, for example with only one (
It will be understood, that the delivery devices and methods can also be used for other intraluminal devices 2, including larger devices, and are not limited to use with intraluminal devices 2 having only one or two columns of cells.
Returning now to
As shown, the outer sheath 12 is a braided shaft and the proximal housing 24 is a bifurcation luer that connects to the outer sheath through a strain relief 30. The strain relief 30 can take any form, such as being made of polyolefin or other similar material.
The bifurcation luer 24 has a main arm to receive the inner shaft 26 and a side arm. The bifurcation luer can be disposed at the proximal end of the outer sheath. The side arm includes a flushing port that is used to flush out air and increase lubricity in the space between the sheath and the inner shaft.
A tuohy borst adapter, hemostatic valve, or other sealing arrangement 32 can be provided proximal of or integrated into the bifurcation luer 24 to receive and seal the proximal end of the space between the inner shaft 26 and the outer sheath 12. The tuohy borst adapter can also provide a locking interface, such as a screw lock, to secure the relationship between the outer sheath and the inner shaft. This can allow the physician to properly place the distal end without prematurely deploying a tack.
The inner shaft is shown with a proximal luer hub 34 and deployment reference marks 36. The deployment reference marks 36 can correspond with the delivery platforms 8, such that the spacing between each deployment reference mark can be the same as the spacing between features of the delivery platforms. For example, the space between deployment reference marks can be the same as the distance between the centers of the delivery platforms.
In some embodiments, a distal most deployment reference mark, or a mark that is different from the others, such as having a wider band or different color, can indicate a primary or home position. For example a deployment reference mark with a wider band than the others can be aligned with the proximal end of the bifurcation luer 24 or hemostatic valve 32. This can indicate to a physician that the outer sheath is in a position completely covering the inner shaft 26 proximal of the nose cone 38. In some embodiments, this alignment can also translate to alignment of the RO marker 28 on the outer sheath to a RO marker on the distal end of the inner shaft 26.
In some embodiments, one or more of the deployment reference marks 36 can represent the number of tacks that are within the system. Thus, once a tack is released, the deployment reference mark 36 will be covered up and the physician can know that the remaining deployment reference marks correspond with the remaining number of tacks available for use. In such an embodiment, the proximal end of the bifurcation luer 24 or hemostatic valve 32 can be advanced to be centered approximately between two reference marks to indicate deployment. It will also be understood that the delivery device could have a handle or trigger assembly such as those described in U.S. Provisional Appl. No. 62/109,550, filed Jan. 29, 2015, and U.S. Pat. No. 9,192,500, both of which are incorporated by reference herein and are to be considered a part of this specification.
Looking now to
Parts of a delivery platform 8 are also shown. The delivery platforms 8 are identical in the illustrated embodiment, though other embodiments can have different sizes and constructions between different delivery platforms. A crimped or compressed tack 2 is shown in the delivery platform 8.
As can be seen in
One or more of the annular pusher bands 44 can be radiopaque marker bands. For example, proximal and distal radiopaque marker bands 44 can be provided to make the ends of the platform 8 visible using standard visualization techniques. The annular marker bands 44 can take any suitable form, for example including one more of tantalum, iridium, and platinum materials. In some embodiments, the pusher bands 44 can be 4 mm long with 6.75 mm recesses between them. A tack of 6.5 mm can be positioned between the pusher bands 44. In some embodiments, the pusher bands can be between 50-70% of the size of the recess and/or the tack. In some embodiments, the pusher bands are about 60%. In other embodiments, the pusher bands can be much smaller, at between 10-20% of the size of the recess and/or the tack. This may be the case especially with longer tacks. In some embodiments, at least the proximal ends of the pusher bands 44 can have a radius to help reduce potential for catching on deployed tacks during retraction of the delivery device.
Reducing the difference in length between the recess and the tack can increase the precision of placement of the tack, especially with tacks having only one or two columns of cells. In some embodiments, the recess can be less than 1, 0.5, 0.4, 0.3, 0.25, or 0.2 mm longer than the tack. The tack can be any number of different sizes, such as 4, 5, 6, 6.5, 8, 10, or 12 mm in length.
The outer sheath 12 can be made of polyether block amide (PEBA), a thermoplastic elastomer (TPE) available under the trade name PEBAX. In some embodiments, the outer sheath 12 can have a thinner inner liner made of a polytetrafluoroethylene (PTFE) such as TEFLON. Any radiopaque marker band(s) 28 or other radiopaque material may be positioned between these two layers. In other embodiments, the radiopaque marker band(s) 28, or other radiopaque material can be embedded within one or more layers of the outer sheath 12. The radiopaque marker band(s) 28 can range from 0.5 mm to 5 mm wide and be located from 0.5 mm to 10 mm proximal from the distal-most tip 52. In some embodiments, the radiopaque marker band(s) 28 can be 1 mm wide and 3 mm proximal from the distal-most tip 52.
In the cross section of
The sleeve 46 can be sized so that with the tack 2 in the delivery platform 8 there is minimal to no space between the tack and the outer sheath. In some embodiments, the sleeve 46 can be co-molded with or extruded onto the inner shaft 26. In some embodiments, the delivery device 10 can be formed with a single sleeve 46 extending over a length of the inner shaft 26. For example, the sleeve can extend from the first delivery platform to the last delivery platform. The annular bands 44 may surround distinct sections of sleeve 46, or they may be encased by the sleeve 46. In some embodiments, each delivery platform 8 has a separate sleeve 46 positioned in the recess 42. The annular bands 44 may be encased by a different material, or may not be encased at all.
As will be understood from
The sleeve of
In some embodiments, an inner shaft 26 can have a lower durometer sleeve 46 between pushers 44. A tack 2 can be crimped onto the sleeve 46 and an outer sheath 12 can constrain the crimped tack in place. The clearance between the sleeve 46 and the outer sheath 12 can result in a slight interference fit between the crimped tack 2 and the inner and outer elements. This slight interference allows the delivery system to constrain the crimped tack during deployment until it is almost completely unsheathed allowing the distal portion of the tack to “flower petal” open and engage the vessel wall, reducing the potential for jumping.
According to some embodiments, the inner shaft 26 can be made of a polyimide-PEBA combination and the lower durometer PEBA sleeve 46 can be thermally bonded in between pushers 44. A tack 2 can be crimped onto the sleeve 46 and a PTFE lined outer sheath 12 can constrain the crimped tack in place.
Returning to
Moving now to
The tacks are preferably self-expandable. Thus, withdrawing the sheath 12 to reveal a tack 2 allows the tack to deploy from the delivery device 10 by self-expansion. The sheath can be withdrawn in small increments to sequentially deliver tacks at desired locations in a blood vessel. In some embodiments, the small increments can correspond with the deployment reference marks 36. The deployment reference marks 36 can be spaced apart at least the length of the tack, so that each tack can be deployed at once, rather than the gradual release typical of a longer stent. This can allow for more precise placement of the tack.
Balloon angioplasty is an accepted method of opening blocked or narrowed blood vessels in every vascular bed in the body. Balloon angioplasty is performed with a balloon angioplasty catheter. The balloon angioplasty catheter consists of a cigar shaped, cylindrical balloon attached to a catheter. The balloon angioplasty catheter is placed into the artery from a remote access site that is created either percutaneously or through open exposure of the artery. The catheter is passed along the inside of the blood vessel over a wire that guides the way of the catheter. The portion of the catheter with the balloon attached is placed at the location of the atherosclerotic plaque that requires treatment. The balloon is inflated to a size that is consistent with the original diameter of the artery prior to developing occlusive disease. In some instances the balloon is coated with, or otherwise configured to deliver, a drug or biologic to the tissue. When the balloon is inflated, the plaque is broken. Cleavage planes form within the plaque, permitting the plaque to expand in diameter with the expanding balloon. Frequently, a segment of the plaque is more resistant to dilatation than the remainder of the plaque. When this occurs, greater pressure pumped into the balloon results in full dilatation of the balloon to its intended size. The balloon is deflated and removed and the artery segment is reexamined. The process of balloon angioplasty is one of uncontrolled plaque disruption. The lumen of the blood vessel at the site of treatment is usually somewhat larger, but not always and not reliably.
Some of the cleavage planes created by fracture of the plaque with balloon angioplasty can form a dissection. More generally, a dissection occurs when a portion of the plaque or tissue is lifted away from the artery, is not fully adherent to the artery and may be mobile or loose. The plaque or tissue that has been disrupted by dissection protrudes into the flow stream. If the plaque or tissue lifts completely in the direction of blood flow, it may impede flow or cause acute occlusion of the blood vessel. There is evidence that dissection after balloon angioplasty must be treated to prevent occlusion and to resolve residual stenosis. There is also evidence that in some circumstances, it is beneficial to place a metal retaining structure, such as a stent or other intraluminal device to hold open the artery after angioplasty and/or force the dissected material back against the wall of the blood vessel to create an adequate lumen for blood flow.
A variety of delivery methodologies and devices can be used to deploy an intraluminal device, such as a tack 2, some of which are described below. For example, a tack can be delivered into the blood vessel with an endovascular insertion. The delivery devices for the different embodiments of plaque tacks can be different or the same and can have features specifically designed to deliver the specific tack. The tack and installation procedure may be designed in a number of ways that share a common methodology of utilizing an expansion force of the delivery mechanism (such as balloon expansion) and/or the expansion force of an undulating ring to enable the tack to be moved into position in the blood vessel, then released to an expanded state within the blood vessel. A tack deployment method can include alignment of radiopaque markers on the outer sheath and the tack to be deployed prior to deployment.
Referring now
The delivery device can be advanced over a guidewire 50 in a patient's vasculature to a treatment site. The guidewire 50 can be the same guidewire used in a prior step of a procedure, such as the guidewire used to position an angioplasty balloon. Once positioned at the treatment location, the outer sheath 12 can be withdrawn or retracted to second pre-deployment position (
According to some embodiments, the outer sheath 12 can have a radiopaque annular marker band 28 and the tack can also have one or more radiopaque markers 22. The radiopaque markers 22 can be positioned in a column around the tack. The distance “L” from the distal end of the tack to the radiopaque marker 22 can be the same as the distance from the distal end 52 of the outer sheath 12 to the radiopaque annular marker band 28. In some embodiments, this distance is to the center of the markers 22 and marker band 28. In some embodiments, the length “L” on the outer sheath is at least as long as the length “L” on the tack, if not slightly longer. The outer sheath can be free from other radiopaque markers. In addition, the tack can also be free from other radiopaque markers or columns of radiopaque markers. Thus, the outer sheath can have only a single marker band 28 at the distal end that is spaced from the distal-most end 52 of the outer sheath 12 by at least a distance from the distal-most end of the tack 2 to a radiopaque marker 22 or column of radiopaque markers. In the illustrated embodiment, the radiopaque marker 22 or column of radiopaque markers are positioned in the middle of the device. The radiopaque markers are also positioned on bridge members 18 that connect adjacent rings of undulating struts 16. In some embodiments, the radiopaque marker 22 or column of radiopaque markers can be spaced from the distal-most end of the tack by at least one ring of undulating struts 16. In the illustrated embodiment, the radiopaque marker 22 or column of radiopaque markers is not at the distal-most end of the tack 2, but is spaced therefrom.
Having corresponding radiopaque markers 22, 28 on the tack and the outer sheath can allow the physician to align the markers 22, 28 prior to deployment of the tack. Further, the physician can align the aligned markers with the desired area to be treated. As will be understood, all of this alignment can be done using standard visualization techniques. As has been mentioned, the annular pusher bands 44 on the inner shaft can also be radiopaque. In some embodiments, the pusher bands 44 can be identical and can appear different under visualization than both the marker on the outer sheath and the marker on the tack. Thus, it can be clear to the physician where all of the markers are and which is which. For example, the pusher bands 44 can be axially longer than the marker 28 on the outer sheath and the marker on the tack. Further, the markers on the delivery device can be bands, while the marker(s) on the tack can be dots.
Looking to
In some embodiments, the delivery device can have a marker band on the outer sheath positioned proximally from the distal end-one at least half the length of the tack, the tack having a single column of markers at the middle of the device. A method of deployment can include withdrawing the outer sheath until the marker on the outer sheath and the tack to be delivered are aligned, and then aligning these two markers with the middle of the lesion to be treated (or other treatment area) before release of the tack, the release being affected by further withdrawing the outer sheath. It will be understood that markers on the pusher bands 44 can also be used to help align the delivery device before deployment.
The method can be repeated to deliver multiple tacks (see
As discussed previously, in some embodiments, simultaneous placement of the entire tack can result upon release of the tack from the delivery device. Further, multiple tacks can placed as desired in a distal to proximal placement within the treatment segment of the vessel.
In some embodiments an expandable tack, such as that shown in
There are instances where drug coated balloons are being used as an alternative to placing a stent in the vessel. The balloon can dilate narrowing in the vessel and the drug helps to minimize post inflation inflammatory response which can lead to a re-narrowing of the artery. There is clinical evidence that the combination of a balloon and drug can provide an alternative to the implantation of a typical stent which have been historically used to provide both short term and long term scaffolding. Drug coated balloons are desirable in that there is no long term implant placed in the vessel. There are instances however when the expansion of a drug coated balloon may cause damage to the vessel in the form of a tissue dissection in which case a flap or piece of tissue extends into the lumen of the vessel. The dissection can occur within the balloon treatment zone as well as outside of or adjacent to the treatment zone. In these instances it is helpful to tack the dissected tissue against the arterial wall. A tack having a low outward force can beneficially be used to treat the dissection where a stent may not be appropriate, or desirable.
In some embodiments, the precise placement of the tack can be set upon positioning of the catheter within the vessel based on the position of a marker. Once positioned, one or more tacks can then be deployed while maintaining the catheter in place and slowly removing the outer sheath.
In some embodiments, one or more tacks can be deployed at a dissection of tissue. When an angioplasty procedure is performed there are typically one of three outcomes: 1) an optimal outcome, no further stenting or over treatment needs to be performed, 2) residual stenosis, usually requiring the placement of a stent to prop open or scaffold the vessel so that it remains open and does not return to the prior occluded or partially occluded state, and 3) a tissue dissection. A tissue dissection can be where the vessel experiences trauma such as the disruption of an arterial wall resulting in separation of the intimal layer. This may or may not be flow limiting. One or more tacks can beneficially be deployed at such a tissue dissection. Small tacks allow for the treatment of a subset of the portion of the blood vessel treated by the balloon angioplasty procedure thereby providing a treatment therapy with does not require the implantation of long metal stents over the entire angioplasty treatment area. Ideally, one or more tacks could be used to treat 60% or less of the length of vessel in the angioplasty treatment area. Small tacks having a single (illustrated) or double column of cells, have been shown to cause less injury and to have shorter recovery times than commonly available stents in treating tissue dissections.
Upon placement of the tack, an intravascular construct is formed in situ. The in situ placement can be in any suitable vessel, such as in any peripheral artery. The construct need not be limited to just two tacks. In fact, a plurality of at least three intravascular tacks can be provided in an intravascular construct formed in situ. In one embodiment each tack has a length of no more than about 8 mm, e.g., about 6 mm in an uncompressed state. In one configuration, at least one of, e.g., each of, the tacks are spaced apart from an adjacent tack by at least about 4 mm, or between about 4 mm and 8 mm or between about 6 mm and 8 mm. Although certain embodiments have a length of 8 mm or less, other embodiments can be longer, e.g., up to about 12 or 15 mm long. Also, neighboring tacks can be positioned as close as 2 mm apart, particularly in vessels that are less prone to bending or other movements. In some embodiments, a delivery device can be preloaded with six tacks, each about 6.5 mm long, and can be used to treat lesions up to 15 cm in length.
In the various delivery devices described herein, the spacing between implanted tacks can be controlled to maintain a set or a minimum distance between each tack. As can be seen, the delivery devices and/or tacks can include features that help maintain the desired distance between tacks. Maintaining proper inter-tack spacing can help ensure that the tacks are distributed over a desired length without contacting each other or bunching up in a certain region of the treated vessel. This can help to prevent kinking of the vessel in which they are disposed.
While a three tack construct formed in situ may be suitable for certain indications, an intravascular construct having at least 5 intravascular tacks may be advantageous for treating loose plaque, vessel flaps, dissections or other maladies that are significantly more elongated (non-focal). For example, while most dissections are focal (e.g., axially short), a series of dissections may be considered and treated as a more elongated malady.
In some cases, even shorter axial length tacks can be used to treat even more spaced apart locations. For example, a plurality of tacks, each having a length of no more than about 7 mm, can be placed in a vessel to treat a tackable malady. At least some of the tacks can be spaced apart from an adjacent tack by at least about 5 mm. In some cases, it may be preferred to provide gaps between adjacent tacks that can range from about 6 mm to about 10 mm.
Once the vascular implants, e.g., tacks 2, are placed, there may be areas of the implant that are not fully apposed to the native vessel wall. This may be due to inner lumen wall surface irregularities. Areas where the implant is not fully apposed to the luminal surface may lead to suboptimal hemodynamic flow. Therefore, optionally, to ensure full apposition of the deployed vascular implant, e.g., tack 2, a device may be inserted to further expand the tack 2. For example, a balloon catheter may be introduced for post-deployment dilation, positioned within the tack 2, and then dilated to gently force the struts of the tack 2 against the luminal wall.
Using a separate device, such as the original, or a new, angioplasty balloon, to expand the tacks to the desired state of expansion, as just discussed, requires placing the tack 2 with the delivery device 10, removing the delivery device 10, inserting a new device (e.g., a new balloon or the angioplasty balloon, dilating the new device to expand the tack 2, deflating the new device, and removing the new device from within the vasculature. This additional catheter exchange results in more procedure time and cost, and creates the potential for undesirable interactions with the implants, such as dislodgement, and the potential for vessel wall injury.
Therefore, some embodiments of the delivery device 10 include a portion for post-deployment dilation of the tack 2. Various embodiments an implant delivery system are disclosed that comprise various post deployment dilation devices that provide an integrated dilatation feature (e.g., a mechanical dilation feature). The dilation feature can be used to ensure optimal implant anchoring and circumferential implant apposition to the vessel inner lumen following deployment of a self-expanding vascular implant. Advantages offered by onboard post deployment dilation devices may include: deployment of a plurality of self-expanding implants; elimination of catheter exchanges needed for post-dilatation of a self-expanding implant and the difficulties and risks associated with the exchange procedure; reduction or elimination of the cost associated with consuming an additional balloon catheter for post-dilation of the implant; shortening procedure durations; and reducing ultimate costs.
The delivery device can be the same as the other delivery devices discussed herein with the addition of a post deployment dilation device. The post deployment dilation device can include an expansion element and an expansion control 1730. The expansion element can take a number of forms, including, for example, expansion filaments 1710, 1910, a bellow 2010, or inner core balloon 2110. In some embodiments, the expansion element comprises a movable frame where one end of the frame is configured to move towards the other end to thereby expand the frame. The frame can be made of expansion filaments 1710, 1910, or a bellow 2010, among other designs. The expansion element can be positioned in a deployment platform.
The expansion control 1730 can be positioned at the proximal end of the delivery device 10 and may be actuated by a user to control expansion of the expansion element. In some embodiments, the expansion control 1730 can be a trigger, a cable, or an end of one or more filaments.
The post deployment dilation device can include one or more radiopaque markers, such as bands or rings 1720, 1722. The one or more radiopaque markers can be at one or more ends, the center, or at other locations of the post deployment dilation device. The one or more radiopaque markers may also be movable with the expansion of the expansion element. In some embodiments, the distal most annular pusher band 44 on the inner shaft can define the proximal end of the post deployment dilation device. The nose cone 38 can define the distal end of the post deployment dilation device. As both the nose cone 38 and the pusher band 44 can be radiopaque, the post deployment dilation device may not include any additional radiopaque markers.
Generally speaking, the delivery device 10 may include one or more delivery platforms, as described herein, which may be exposed by the proximal axial sliding of an outer sheath 12 (they alternatively may be covered by the distal axial sliding of an outer sheath 12). The delivery platforms are configured to accept and hold one or more intraluminal devices (e.g., self-expanding tacks 2). The intraluminal devices may be released or deployed within a volume, such as a blood vessel, by withdrawing the outer sheath 12 to expose the delivery platform. In addition to the delivery platforms that are configured to hold and then release one or more (e.g., a plurality) or intraluminal devices, the delivery device 10 may include a post deployment dilation device.
As disclosed herein, post deployment dilation devices are part of the delivery device 10, at least a portion of which may be positioned within a deployed or already-expanded intraluminal device (e.g., a self-expanding tack 2 that has been allowed to expand). The post deployment dilation devices disclosed herein may have a first pre-deployment diameter that is substantially the same as or close to the diameter of an inner portion of the delivery device. They may also have a second deployment diameter that is larger than the first pre-deployment diameter. Once positioned within the intraluminal device, the post deployment dilation device may be radially expanded to push outwardly on the inner surface of the intraluminal device. Stated differently, the post deployment dilation device is configured such that at least a portion of the post deployment dilation device contacts at least a portion of the inner surface of an intraluminal device and applies a radial force to that inner surface of the intraluminal device. By the application of an outward or radial force to the inside of the intraluminal device (i.e., at least a portion of the inner surface of the intraluminal device), the post deployment dilation device may cause the intraluminal device to expand even further and/or seat more evenly against the surface of the volume in which it is contained (e.g., the blood vessel). After the post deployment dilation device has expanded to exert and outward/radial force on the intraluminal device, it may be contracted or compressed so that it may be moved out from underneath (e.g., withdrawn) from within the intraluminal device without entanglement with the intraluminal device.
A delivery device 10 may include only one, or multiple, post deployment dilation devices. When only one post deployment dilation device is included, the post deployment dilation device may be located distal of the first delivery platform, between a first and second delivery platform, underneath a delivery platform, or even proximal to all delivery platforms. A delivery device delivery device 10 may include more than one post deployment dilation device, for example, two, three, four, five, or six, post deployment dilation devices. When more than one post deployment dilation device is included, the post deployment dilation devices may be located distal and proximal to the delivery platforms, between two or more of the delivery platforms, or within two or more of the delivery platforms.
As described elsewhere herein, the delivery device 10 may be operated/actuated at its proximal end, for example to withdraw the outer sheath 12 and deploy one or more tacks 2. In much the same way, the post deployment dilation devices disclosed herein may be actuated from the proximal end of the delivery device 10. That way, an operator may insert the delivery device 10 into a volume, e.g., a patient's blood vessel, advance the delivery device 10 to a target site, withdraw the outer sheath 12, deploy a tack 2, and use the post deployment dilation device, all from the proximal end of the delivery device 10.
At least some embodiments of the post deployment dilation device include a plurality of expansion filaments 1710, 1910 as shown in
When fixed with respect to the distal end of the post deployment dilation device (
Alternatively, the expansion filaments 1910 may be fixed with respect to the proximal end of the post deployment dilation device (
In some embodiments, the expansion filaments 1910 can be positioned within a lumen in the inner member and distal movement of the ring 1920 can withdraw the filaments 1910. The filaments 1910 can then assume a pre-bent or shaped expanded form to further expand the intraluminal device.
Another post deployment dilation device disclosed herein includes a flexible bellow (
Still other post deployment dilation devices disclosed herein include an inflatable balloon (e.g., an inner core balloon 2110,
One or more embodiment incorporating a balloon into the post deployment dilation device also includes a helical coil 2330 (
Like the systems shown in prior figures, the outer sheath 12 can have a radiopaque annular marker band 28 and the tack can also have one or more radiopaque markers 22. The radiopaque markers 22 can be positioned in a column around the tack. Having corresponding radiopaque markers 22, 28 on the tack and the outer sheath can allow the physician to align the markers 22, 28 prior to deployment of the tack as shown in
With reference to
As mentioned above, the post deployment dilation device includes a plurality of expansion filaments 1710. The expansion filaments 1710 can form a frame. In some embodiments, the post deployment dilation device has 3 expansion filaments 1710. In other embodiments, the post deployment dilation device has distal end 4, 5, 6, 7, 8, 9, 10, 11, or 12 expansion filaments 1710. On still other embodiments, the post deployment dilation device has more than 12 expansion filaments 1710. The expansion filaments 1710 are fabricated out of a flexible material that retains enough rigidity that it can push radially outward, as will be discussed below. In some embodiments, the expansion filaments 1710 are made out of a polymer. In other embodiments, the expansion filaments 1710 are made out of a metal, such as a super-elastic metal (e.g., nitinol). The distal portion of each expansion filament 1710 can be pre-shaped to allow for optimal engagement with the inner surface of an implant and subsequent expansion of the implant. In some embodiments, each expansion filament 1710 is covered by a thin, flexible polymer film. This may advantageously help distribute the expansion forces more equally over the surface area of the intravascular device. The polymer film may also help mitigate the potential for entanglement of the filaments into the structure of the intravascular device during dilation. The polymer film can also be used to deliver drugs or biologic therapies to the wall of the blood vessel. Alternatively, in other embodiments, the expansion filaments 1710 may be embedded in the wall of a very fine, very flexible, continuous, expandable structure, such as a balloon. Being so embedded advantageously prevents the expansion filaments 1710 from becoming entangled with and/or caught on the struts or anchors of the tack 2 that is being deployed.
As illustrated, the distal portion of each expansion filament 1710 in the plurality of expansion filaments 1710 is fixed with respect to the inner shaft 26 near the distal end of the post deployment dilation device's platform (e.g., near the distal radiopaque ring 1720). They are fixed in approximately equal divisions around the delivery device 10. For example, in an embodiment in which the post deployment dilation device has only 3 expansion filaments 1710, each expansion filament 1710 is separated from the next expansion filament 1710 by about 120°. In the same way, in an embodiment of the delivery device 10 in which the post deployment dilation device has 6 expansion filaments 1710, each expansion filament 1710 is separated from the next expansion filament 1710 by about 60°.
The expansion filaments 1710 extend proximally from their attachment points with respect to the inner shaft 26, over the post deployment dilation device's platform, and underneath the annular marker bands 44 and the various delivery platforms 8, to a proximal end of the delivery device 10. The various expansion filaments 1710 may each, individually extend all the way to a proximal end of the delivery device 10. Alternatively, the various expansion filaments 1710 may join together, proximal of the post deployment dilation device's platform, to form a single cable that extends proximally to the proximal end of the delivery device 10. A proximal portion of each expansion filament 1710 (or, as just discussed, the single cable comprising each and every expansion filament 1710), is fixed to an expansion control 1730 at the proximal end of the delivery device 10 that may be actuated by a user, e.g., the physician.
In some embodiments, the inner shaft 26 is extruded to include a plurality of lumens through which the expansion filaments 1710 may travel from the post deployment dilation device to the proximal end of the delivery device 10. The inner shaft 26 may consist of a multi-lumen extrusion as shown in
As will be readily understood, the inner shaft 26 may include any number of filament lumens 1810, including 3 filament lumens 1810. In some embodiments, the inner shaft 26 has 4, 5, 6, 7, 8, 9, 10, 11, or 12 filament lumens 1810. In yet other embodiments, the inner shaft 26 has more than 12 filament lumens 1810. Each filament lumen 1810 may contain an expansion filament 1710. For example, an inner shaft 26 may be extruded with a certain number of filament lumens 1810 (e.g., 8 filament lumens 1810) then the same number of expansion filaments 1710 (i.e., 8 expansion filaments 1710) are inserted into the filament lumens 1810. Such 1:1 ratios may be useful for highly tailored systems. However, by contrast, some of the extruded filament lumens 1810 may remain empty. For example, an inner shaft 26 may be extruded with a comparatively large number of filament lumens 1810 (e.g., 12 filament lumens 1810). Then, only the desired number of expansion filaments 1710 (e.g., 6 expansion filaments 1710) are inserted into the filament lumens 1810. This type of system is more modular and may decrease manufacturing costs as a single extruded inner shaft 26 may accommodate various numbers of expansion filaments 1710.
As shown in
In some embodiments, the expansion filaments 1710 can exit the filament lumens 1810 adjacent to a pusher band 44. In this way the pusher band 44 can be used to increase the rigidity and structural integrity of the inner member 26. The nose cone 38 can also be used in this manner. For example, metal radiopaque marker bands in the pusher band 44 and in the nose cone 38 can surround the filament lumens 1710 adjacent the exits locations of the expansion filaments. This can help the delivery device deal with the increased stress on the inner member when the expansion filaments are in the expanded position. As has been mentioned, the pusher band and nose cone can define the respective proximal and distal ends of the post deployment dilation device.
As illustrated, in the post deployment dilation device's pre-deployment state, each expansion filament 1710 lies substantially flat against the inner shaft 26 (or in a filament recess 1820 of the inner shaft 26). In the pre-deployment state, there is little, if any, slack in each expansion filament 1710. That is to say that the length of the expansion filament 1710 between its fixation point at the distal end of the post deployment dilation device's platform and the distal end of the filament lumen 1810 is about the same as the length of the post deployment dilation device's platform.
Activation of the expansion mechanism causes the distal advancement of the filaments through the lumens, which further results in the radial expansion of a distal portion of the filaments through the openings in the wall of the extrusion. Deployment (i.e., activation of the expansion mechanism) is accomplished by pushing on the proximal ends of the various expansion filaments 1710 (or the cable formed by the various expansion filaments 1710). This causes the expansion filament 1710 to extend out of the distal end of its filament lumen 1810 (e.g., distal advancement of the filaments through the lumens), thereby resulting in an extension and radial expansion of a distal portion of the expansion filaments 1710 through the filament lumens 1810, which further results in the radial expansion of a distal portion of the filaments through the openings in the wall of the extrusion. Extension of the distal portion of an expansion filament 1710 increases the length of the expansion filament 1710 between the attachment point at the distal end of the post deployment dilation device and the distal end of the filament lumen 1810. As the length of the expansion filament 1710 above the post deployment dilation device increases, it will “buckle” outward. Pushing more of the expansion filament 1710 out of the filament lumen 1810 causes the expansion filament 1710 to buckle even further outward. That is to say, the expansion diameter of the expansion filaments 1710 is controlled by the longitudinal displacement of the proximal end of the expansion filaments 1710.
Once the tack 2 has been deployed to its target location and stopped expanding within the vessel (i.e., no more or very little motion of the radiopaque markers 22 is observed), the delivery device 10 is moved either proximally or distally and repositioned such that the post deployment dilation device is moved underneath the tack 2, shown in
A portion of the inner shaft 26 or a portion of the expansion filaments 1710, can include one or more radiopaque elements to allow for optimal longitudinal alignment of the expansion filaments 1710 within the deployed implant. For example, the post deployment dilation device may incorporate the distal radiopaque ring 1720 and the proximal radiopaque ring 1722, which can be used to center the post deployment dilation device within the center of the tack 2. The distal radiopaque ring 1720 and the proximal radiopaque ring 1722 can be observed using conventional imaging techniques, just like the radiopaque markers 22. Consequently, the physician may advance or retract the delivery device 10 until the radiopaque markers 22 lie substantially in the middle of the distal radiopaque ring 1720 and the proximal radiopaque ring 1722. At that point, the tack 2 will be in approximately the center of the post deployment dilation device—the proper location for activation of the post deployment dilation device.
When the post deployment dilation device is centered under the implant, the expansion mechanism may be activated by pushing distally on the proximal ends of the expansion filaments 1710, or the proximal end of the cable comprising the expansion filaments 1710, at the proximal end of the expansion filament 1710. As described above, this causes expansion of each expansion filament 1710 out of its distal sectioned pocket or recess. The radial expansion of the expansion filaments 1710, or “buckling,” causes the filaments to engage with the inner surface of the vascular implant, as shown in
Following radial expansion of the expansion filaments 1710 and complete deployment of the tack 2, the expansion mechanism can be deactivated by pulling proximally on the proximal ends of the expansion filaments 1710, or the proximal end of the cable comprising the expansion filaments 1710, at the proximal end of the expansion filament 1710. As described above, this causes each expansion filament 1710 to retract back into its distal sectioned pocket or recess, to once again lie flat against the inner shaft 26, shown in
While the post deployment dilation device shown in
The illustrated post deployment dilation device generally includes distal radiopaque ring 1720, a proximal radiopaque ring 1722, and a plurality of expansion filaments 1910. Distal radiopaque ring 1720 and proximal radiopaque ring 1722 may be the same as has already been described with respect to
By contrast to
The expansion filaments 1910 extend distally from their attachment points with respect to the inner shaft 26, over the post deployment dilation device's platform, and attach to a sliding sleeve 1920. The expansion filaments 1910 may be contained within pockets or recesses, when not deployed, as has already been described. The length of the expansion filaments 1910 (e.g., when straight and unbent) result in the sliding sleeve being positioned in its relative “home” position (e.g., near the distal radiopaque ring 1720) with no preload, shown in
In operation, the retractor may be pulled proximally, thereby causing the sliding sleeve 1920 to slide proximally along the surface of the inner shaft 26.
Once the tack 2 has been deployed to its target location and stopped expanding within the vessel (i.e., no more or very little motion of the radiopaque markers 22 is observed), the delivery device 10 is moved either proximally or distally and repositioned such that the post deployment dilation device is moved underneath the tack 2, shown in
Radiopaque markers, e.g., distal radiopaque ring 1720 and proximal radiopaque ring 1722 may be used to align the post deployment dilation device with the tack 2. In some embodiments, the distal radiopaque ring 1720 and the proximal radiopaque ring 1722 are used to align the tack 2 in the center of the post deployment dilation device. In other embodiments, the proximal radiopaque ring 1722 is positioned closer to the radiopaque markers 22 of the tack 2 (shown in
When the post deployment dilation device is located in the desired position under the implant, the expansion mechanism may be activated by pulling proximally on the retractor. As described above, this causes the sliding sleeve 1920 to slide proximally and the expansion filament 1910 to radially expand outwards, as shown in
Following radial expansion of the expansion filaments 1910 and complete deployment of the tack 2, the expansion mechanism can be deactivated by pushing distally on the retractor, e.g., at the proximal end of the delivery device 10. As described above, this causes each expansion filament 1910 to retract back into its distal sectioned pocket or recess, to once again lie flat against the inner shaft 26.
While the post deployment dilation device shown in
The post deployment dilation device generally includes a bellow 2010. The proximal end of the bellow 2010 is generally attached to the inner shaft 26 near or at the proximal end of the post deployment dilation device's platform. The distal end of the bellow 2010 is attached to a sliding sleeve or ring 2020. The sliding sleeve 2020 may be operatively coupled to an expansion control 1730 or retractor at the proximal end of the delivery device 10. The retractor allows a user to cause the sliding sleeve 2020 to slide, coaxially, along the inner shaft 26. In some embodiments, the retractor is simply a series of filaments attached to the sliding sleeve 2020, extending over the surface of the post deployment dilation device's platform, into the wall of the inner shaft 26 (e.g., through filament lumens 1810), and to the proximal end of the delivery device 10.
The sliding sleeve 2020 may be positioned in its relative “home” position (e.g., near the distal radiopaque ring 1720), shown in
In operation, the retractor may be moved proximally, thereby causing the sliding sleeve 2020 to slide proximally along the surface of the inner shaft 26. In some embodiments, the retractor is pulled proximally. However, in other embodiments, the axial force in the distal direction is merely decreased to allow the retractor to move proximally.
While the post deployment dilation device shown in
The post deployment dilation device generally includes distal radiopaque ring 1720, a proximal radiopaque ring 1722, and an inner core balloon 2110. Distal radiopaque ring 1720 and proximal radiopaque ring 1722 may be the same as has already been described with respect to
The inner core balloon 2110 may extend from about the distal radiopaque ring 1720 or the distal end of the post deployment dilation device's platform to about the proximal radiopaque ring 1722 or the proximal end of the post deployment dilation device's platform. As illustrated in
In some embodiments, the inner core balloon 2110 has a pre-deployment diameter that is only marginally larger than the inner shaft 26. In such embodiments, the pre-deployment diameter is sufficiently small that the inner core balloon 2110 may reside between the inner shaft 26 and the outer sheath 12. In some embodiments, the inner core balloon 2110 may have a fully expanded diameter of about 8 mm. In other embodiments, the inner core balloon 2110 has an expanded diameter of about 0.4, 0.6, 0.8, 1, 1.2, 1.4, 1.6, 1.8, 2, 2.2, 2.4, 2.6, 2.8, 3, 3.2, 3.4, 3.6, 3.8, 4, 4.2, 4.4, 4.6, 4.8, 5, 5.2, 5.4, 5.6, 5.8, 6, 6.2, 6.4, 6.6, 6.8, 7, 7.2, 7.4, 7.6, 7.8, 8, 8.2, 8.4, 8.6, 8.8, 9, 9.2, 9.4, 9.6, 9.8, or 10 mm. In other embodiment, the 2110 has any other expanded diameter that is appropriate for fully deploying a vascular device within a subject's vasculature.
The inner core balloon 2110 can be inflated by a fluid transferred from the proximal end of the delivery device 10 to the inner core balloon 2110 through one or more lumens. In some embodiments, the inner shaft 26 is extruded to include one or more lumens through which fluids may travel from one end of the delivery device 10 to the other. The inner shaft 26 may consist of a multi lumen extrusion as shown in
As will be readily understood, while two fluid lumens 2220 are shown, the inner shaft 26 may include only 1 fluid lumen 2220. In some embodiments, the inner shaft 26 include 3, distal end 4, 5, 6, 7, or even 8 fluid lumens 2220. In other embodiments, the inner shaft 26 includes more than 8 fluid lumens 2220.
In operation, as shown in
Once the tack 2 has been deployed to its target location and stopped expanding within the vessel (i.e., no more or very little motion of the radiopaque markers 22 is observed), the delivery device 10 is moved either proximally or distally and repositioned such that the post deployment dilation device is moved underneath the tack 2, shown in
Radiopaque markers, e.g., distal radiopaque ring 1720 and proximal radiopaque ring 1722 may be used to align the post deployment dilation device with the tack 2 as discussed above. In some embodiments, the distal radiopaque ring 1720 and the proximal radiopaque ring 1722 are used to align the tack 2 in the center of the post deployment dilation device. In other embodiments, the proximal radiopaque ring 1722 is positioned closer to the radiopaque markers 22 of the tack 2.
When the post deployment dilation device is located in the desired position under the implant, the inner core balloon 2110 may be inflated by pumping fluid from the proximal end of the delivery device 10, through the one or more fluid lumens 2220, and into the inner core balloon 2110. As described above, this causes the inner core balloon 2110 to radially expand outwards, as shown in
Following radial expansion of the inner core balloon 2110 and complete deployment of the tack 2, the expansion mechanism can be deactivated by deflating the inner core balloon 2110, e.g., by removing the expansion fluid. In some embodiments, the expansion fluid is removed actively, such as by pumping the fluid out. In other embodiments, the expansion fluid is removed passively, such as by simply opening a purge valve and allowing the expansion to flow out due to the pressure differential that exists. As described above, deflating the inner core balloon 2110 causes the balloon to retract (e.g., due to elastic properties of the inner core balloon 2110) and to once again lie flat against the inner shaft 26.
While the post deployment dilation device shown in
To help confine the inner core balloon 2110 against the inner shaft 26, both before and after use of the post deployment dilation device to deploy a tack 2, a helical filament 2330 may be used. The helical filament 2330 may be an elongate filament having a helical distal end and a long, substantially straight, proximal portion. The helical distal end of the helical filament 2330 need be helical only in the region of the post deployment dilation device and the inner core balloon 2110, as shown in
The helical filament 2330 is preferably made out of a flexible material that retains enough rigidity that it can regain its shape after deformation, as will be discussed below. In some embodiments, the helical filament 2330 is made out of a polymer. In other embodiments, the helical filament 2330 is made out of a metal, such as a super-elastic metal (e.g., nitinol).
In its pre-deployment state, shown in
Following use of the inner core balloon 2110, the inner core balloon 2110 is deflated as described above. Then, the helical filament 2330 can be used to capture and contain the outer diameter of the post-deflated inner core balloon 2110 to minimize the inner core balloon 2110's crossing profile, thereby mitigating potential interactions between an irregularly shaped post-deflated inner core balloon 2110 and deployed implants (e.g., tacks 2) and the vessel. To re-capture the inner core balloon 2110, the helical filament 2330 is extended back out of the helical filament lumen 2320 using one or more of a distal pushing and a twisting motion. As the helical distal portion of the helical filament 2330 extends out of the helical filament lumen 2320, it regains its shape, due to its elastic properties, and helically wraps around the deflated inner core balloon 2110 to confine the inner core balloon 2110 and minimize its deflated crossing profile (shown in
After the helical filament 2330 has been extended back out of the helical filament lumen 2320, the delivery device 10 may be moved proximally or distally to post-dilate another implant. Because the helical filament 2330 confines the inner core balloon 2110, risk of interactions between the irregularly shaped post-deflated inner core balloon 2110 and other structures may be mitigated. Once the post deployment dilation device and inner core balloon 2110 have been position at a desired location relative to another implant (e.g., tack 2), the helical filament 2330 may be retracted into the helical filament lumen 2320 thereby allowing inflation of the inner core balloon 2110. This process may be repeated for successive post-dilations of multiple implants.
In another embodiment, rather than retract the helical filament 2330, the helical filament 2330 can be advanced out of the lumen 2320 to increase its size. Alternatively, filling the balloon 2110 can force the helical filament 2330 to expand with the balloon, pulling the filament out of the lumen 2320. Removing the fluid can allow the helical filament to cinch down on the balloon, retracting itself into the lumen as the balloon decreases in size.
Although this invention has been disclosed in the context of certain preferred embodiments and examples, it will be understood by those skilled in the art that the present invention extends beyond the specifically disclosed embodiments to other alternative embodiments and/or uses of the invention and obvious modifications and equivalents thereof. In addition, while a number of variations of the invention have been shown and described in detail, other modifications, which are within the scope of this invention, will be readily apparent to those of skill in the art based upon this disclosure. It is also contemplated that various combinations or sub-combinations of the specific features and aspects of the embodiments may be made and still fall within the scope of the invention. Accordingly, it should be understood that various features and aspects of the disclosed embodiments can be combined with or substituted for one another in order to form varying modes of the disclosed invention. Thus, it is intended that the scope of the present invention herein disclosed should not be limited by the particular disclosed embodiments described above, but should be determined only by a fair reading of the claims that follow.
Similarly, this method of disclosure, is not to be interpreted as reflecting an intention that any claim require more features than are expressly recited in that claim. Rather, as the following claims reflect, inventive aspects lie in a combination of fewer than all features of any single foregoing disclosed embodiment. Thus, the claims following the Detailed Description are hereby expressly incorporated into this Detailed Description, with each claim standing on its own as a separate embodiment.
This application is the national phase under 35 U.S.C. § 371 of PCT Int'l Appl. No. PCT/US2016/069211, which has an International filing date of Dec. 29, 2016, which claims the benefit of priority of U.S. Provisional Appl. No. 62/369,683, filed on Aug. 1, 2016, and is a continuation-in-part of U.S. patent application Ser. No. 15/000,437, filed Jan. 19, 2016, now U.S. Pat. No. 9,433,520, which claims the benefit of priority of U.S. Provisional Appl. No. 62/274,236, filed on Jan. 1, 2016. The disclosures of the aforementioned applications are hereby incorporated in their entirety herein by reference and are to be considered a part of this specification. Any and all applications for which a foreign or domestic priority claim is identified in the Application Data Sheet as filed with the present application are hereby incorporated.
| Filing Document | Filing Date | Country | Kind |
|---|---|---|---|
| PCT/US2016/069211 | 12/29/2016 | WO | 00 |
| Publishing Document | Publishing Date | Country | Kind |
|---|---|---|---|
| WO2017/117391 | 7/6/2017 | WO | A |
| Number | Name | Date | Kind |
|---|---|---|---|
| 3051172 | Bruchhaus | Aug 1962 | A |
| 3221746 | Noble | Dec 1965 | A |
| 3635223 | Klieman | Jan 1972 | A |
| 4024873 | Antoshkiw et al. | May 1977 | A |
| 4292974 | Fogarty et al. | Oct 1981 | A |
| 4446867 | Leveen et al. | May 1984 | A |
| 4465072 | Taheri | Aug 1984 | A |
| 4515587 | Schiff | May 1985 | A |
| 4545367 | Tucci | Oct 1985 | A |
| 4545390 | Leary | Oct 1985 | A |
| 4552127 | Schiff | Nov 1985 | A |
| 4576591 | Kay et al. | Mar 1986 | A |
| 4589412 | Kensey | May 1986 | A |
| 4641654 | Samson et al. | Feb 1987 | A |
| 4651738 | Demer et al. | Mar 1987 | A |
| 4687465 | Prindle et al. | Aug 1987 | A |
| 4723550 | Bales et al. | Feb 1988 | A |
| 4723936 | Buchbinder et al. | Feb 1988 | A |
| 4723938 | Goodin et al. | Feb 1988 | A |
| 4726374 | Bales et al. | Feb 1988 | A |
| 4758223 | Rydell | Jul 1988 | A |
| 4762130 | Fogarty et al. | Aug 1988 | A |
| 4781192 | Demer | Nov 1988 | A |
| 4784636 | Rydell | Nov 1988 | A |
| 4846174 | Willard et al. | Jul 1989 | A |
| 4848342 | Kaltenbach | Jul 1989 | A |
| RE33166 | Samson | Feb 1990 | E |
| 4921484 | Hillstead | May 1990 | A |
| 4994065 | Gibbs et al. | Feb 1991 | A |
| 5009659 | Hamlin et al. | Apr 1991 | A |
| 5024668 | Peters et al. | Jun 1991 | A |
| 5042707 | Taheri | Aug 1991 | A |
| 5047015 | Foote et al. | Sep 1991 | A |
| 5102390 | Crittenden et al. | Apr 1992 | A |
| 5160341 | Brenneman et al. | Nov 1992 | A |
| 5190058 | Jones et al. | Mar 1993 | A |
| 5196024 | Barath | Mar 1993 | A |
| 5201757 | Heyn et al. | Apr 1993 | A |
| 5242452 | Inoue | Sep 1993 | A |
| 5246420 | Kraus et al. | Sep 1993 | A |
| 5250029 | Lin et al. | Oct 1993 | A |
| 5250060 | Carbo et al. | Oct 1993 | A |
| 5261878 | Galindo | Nov 1993 | A |
| 5263962 | Johnson et al. | Nov 1993 | A |
| 5269758 | Taheri | Dec 1993 | A |
| 5304121 | Sahatjian | Apr 1994 | A |
| 5318529 | Kontos | Jun 1994 | A |
| 5336234 | Virgil et al. | Aug 1994 | A |
| 5344397 | Heaven et al. | Sep 1994 | A |
| 5383890 | Miraki et al. | Jan 1995 | A |
| 5397305 | Kawula et al. | Mar 1995 | A |
| 5397355 | Marin et al. | Mar 1995 | A |
| 5421955 | Lau et al. | Jun 1995 | A |
| 5423851 | Samuels | Jun 1995 | A |
| 5423885 | Williams | Jun 1995 | A |
| 5443477 | Marin et al. | Aug 1995 | A |
| 5489295 | Piplani | Feb 1996 | A |
| 5501689 | Green et al. | Mar 1996 | A |
| 5534007 | St. Germain et al. | Jul 1996 | A |
| 5536252 | Imran et al. | Jul 1996 | A |
| 5540659 | Teirstein | Jul 1996 | A |
| 5545135 | Iacob et al. | Aug 1996 | A |
| 5562728 | Lazarus et al. | Oct 1996 | A |
| 5569272 | Reed et al. | Oct 1996 | A |
| 5571135 | Fraser et al. | Nov 1996 | A |
| 5591197 | Orth et al. | Jan 1997 | A |
| 5593417 | Rhodes | Jan 1997 | A |
| 5601568 | Chevillon et al. | Feb 1997 | A |
| 5616149 | Barath | Apr 1997 | A |
| 5618300 | Marin et al. | Apr 1997 | A |
| 5632771 | Boatman et al. | May 1997 | A |
| 5634928 | Fischell et al. | Jun 1997 | A |
| 5643312 | Fischell et al. | Jul 1997 | A |
| 5645559 | Hachtman et al. | Jul 1997 | A |
| 5665116 | Chaisson et al. | Sep 1997 | A |
| 5681346 | Orth et al. | Oct 1997 | A |
| 5704913 | Abele et al. | Jan 1998 | A |
| 5707376 | Kavteladze et al. | Jan 1998 | A |
| 5725572 | Lam et al. | Mar 1998 | A |
| 5728158 | Lau et al. | Mar 1998 | A |
| 5741270 | Hansen et al. | Apr 1998 | A |
| 5743874 | Fischell et al. | Apr 1998 | A |
| 5746716 | Vigil et al. | May 1998 | A |
| 5746764 | Green et al. | May 1998 | A |
| 5776161 | Globerman | Jul 1998 | A |
| 5797951 | Mueller | Aug 1998 | A |
| 5800526 | Anderson et al. | Sep 1998 | A |
| 5807398 | Shaknovich | Sep 1998 | A |
| 5813977 | Hinchliffe et al. | Sep 1998 | A |
| 5817152 | Birdsall et al. | Oct 1998 | A |
| 5829662 | Allen et al. | Nov 1998 | A |
| 5833694 | Poncet | Nov 1998 | A |
| 5843033 | Ropiak | Dec 1998 | A |
| 5843090 | Schuetz | Dec 1998 | A |
| 5911725 | Boury | Jun 1999 | A |
| 5925038 | Panescu et al. | Jul 1999 | A |
| 5925061 | Ogi et al. | Jul 1999 | A |
| 5928247 | Barry et al. | Jul 1999 | A |
| 5944727 | Ahari et al. | Aug 1999 | A |
| 5954742 | Osypka | Sep 1999 | A |
| 5957949 | Leonhardt et al. | Sep 1999 | A |
| 5968052 | Sullivan, III et al. | Oct 1999 | A |
| 5968068 | Dehdashtian et al. | Oct 1999 | A |
| 5968088 | Hansen et al. | Oct 1999 | A |
| 5972023 | Tanner et al. | Oct 1999 | A |
| 5980552 | Pinchasik et al. | Nov 1999 | A |
| 6004328 | Solar | Dec 1999 | A |
| 6007543 | Ellis et al. | Dec 1999 | A |
| 6009614 | Morales | Jan 2000 | A |
| 6013854 | Moriuchi | Jan 2000 | A |
| 6022374 | Imran | Feb 2000 | A |
| 6036725 | Avellanet | Mar 2000 | A |
| 6048360 | Khosravi et al. | Apr 2000 | A |
| 6053941 | Lindenberg et al. | Apr 2000 | A |
| 6053943 | Edwin et al. | Apr 2000 | A |
| 6080177 | Igaki | Jun 2000 | A |
| 6090135 | Plaia et al. | Jul 2000 | A |
| 6102904 | Vigil et al. | Aug 2000 | A |
| 6110198 | Fogarty et al. | Aug 2000 | A |
| 6123722 | Fogarty et al. | Sep 2000 | A |
| 6126685 | Lenker et al. | Oct 2000 | A |
| 6129754 | Kanesaka et al. | Oct 2000 | A |
| 6139573 | Sogard et al. | Oct 2000 | A |
| 6143016 | Bleam et al. | Nov 2000 | A |
| 6146358 | Rowe | Nov 2000 | A |
| 6152937 | Peterson et al. | Nov 2000 | A |
| 6157852 | Selmon et al. | Dec 2000 | A |
| 6165199 | Barbut | Dec 2000 | A |
| 6187034 | Frantzen | Feb 2001 | B1 |
| 6197013 | Reed | Mar 2001 | B1 |
| 6197103 | Davies et al. | Mar 2001 | B1 |
| 6200336 | Pavcnik et al. | Mar 2001 | B1 |
| 6203550 | Olson | Mar 2001 | B1 |
| 6203568 | Lombardi et al. | Mar 2001 | B1 |
| 6203569 | Wijay | Mar 2001 | B1 |
| 6221102 | Baker et al. | Apr 2001 | B1 |
| 6238402 | Sullivan et al. | May 2001 | B1 |
| 6241667 | Vetter et al. | Jun 2001 | B1 |
| 6254628 | Wallace et al. | Jul 2001 | B1 |
| 6258117 | Camrud et al. | Jul 2001 | B1 |
| 6266550 | Selmon et al. | Jul 2001 | B1 |
| 6270524 | Kim | Aug 2001 | B1 |
| 6273909 | Kugler et al. | Aug 2001 | B1 |
| 6290728 | Phelps et al. | Sep 2001 | B1 |
| 6312444 | Barbut | Nov 2001 | B1 |
| 6312460 | Drasler et al. | Nov 2001 | B2 |
| 6325824 | Limon | Dec 2001 | B2 |
| 6331189 | Wolinsky et al. | Dec 2001 | B1 |
| 6338739 | Datta et al. | Jan 2002 | B1 |
| 6344053 | Boneau | Feb 2002 | B1 |
| 6364901 | Inoue | Apr 2002 | B1 |
| 6364904 | Smith | Apr 2002 | B1 |
| 6371962 | Ellis et al. | Apr 2002 | B1 |
| 6387113 | Hawkins et al. | May 2002 | B1 |
| 6391050 | Broome | May 2002 | B1 |
| 6402760 | Fedida | Jun 2002 | B1 |
| 6402777 | Globerman | Jun 2002 | B1 |
| 6409752 | Boatman et al. | Jun 2002 | B1 |
| 6409863 | Williams et al. | Jun 2002 | B1 |
| 6425915 | Khosravi et al. | Jul 2002 | B1 |
| 6428550 | Vargas et al. | Aug 2002 | B1 |
| 6428566 | Holt | Aug 2002 | B1 |
| 6451047 | Edwin et al. | Sep 2002 | B2 |
| 6458151 | Saltiel | Oct 2002 | B1 |
| 6475237 | Drasler et al. | Nov 2002 | B2 |
| 6485507 | Walak et al. | Nov 2002 | B1 |
| 6485508 | McGuinness | Nov 2002 | B1 |
| 6485510 | Camrud et al. | Nov 2002 | B1 |
| 6491707 | Makower et al. | Dec 2002 | B2 |
| 6508822 | Peterson et al. | Jan 2003 | B1 |
| 6514228 | Hamilton et al. | Feb 2003 | B1 |
| 6514261 | Randall et al. | Feb 2003 | B1 |
| 6517573 | Pollock et al. | Feb 2003 | B1 |
| 6520934 | Lee et al. | Feb 2003 | B1 |
| 6520983 | Colgan et al. | Feb 2003 | B1 |
| 6520984 | Garrison et al. | Feb 2003 | B1 |
| 6527800 | McGuckin, Jr. et al. | Mar 2003 | B1 |
| 6547817 | Fischell et al. | Apr 2003 | B1 |
| 6551353 | Baker et al. | Apr 2003 | B1 |
| 6599296 | Gillick et al. | Jul 2003 | B1 |
| 6602226 | Smith et al. | Aug 2003 | B1 |
| 6607551 | Sullivan et al. | Aug 2003 | B1 |
| 6623521 | Steinke et al. | Sep 2003 | B2 |
| 6629994 | Gomez et al. | Oct 2003 | B2 |
| 6635083 | Cheng et al. | Oct 2003 | B1 |
| 6648911 | Sirhan et al. | Nov 2003 | B1 |
| 6660031 | Tran et al. | Dec 2003 | B2 |
| 6676698 | McGuckin, Jr. et al. | Jan 2004 | B2 |
| 6692504 | Kurz et al. | Feb 2004 | B2 |
| 6699274 | Stinson | Mar 2004 | B2 |
| 6699277 | Freidberg et al. | Mar 2004 | B1 |
| 6702843 | Brown et al. | Mar 2004 | B1 |
| 6706061 | Fischell et al. | Mar 2004 | B1 |
| 6716240 | Fischell et al. | Apr 2004 | B2 |
| 6719775 | Slaker et al. | Apr 2004 | B2 |
| 6723119 | Pinchasik et al. | Apr 2004 | B2 |
| 6730116 | Wolinsky et al. | May 2004 | B1 |
| 6746475 | Rivelli, Jr. | Jun 2004 | B1 |
| 6752828 | Thornton | Jun 2004 | B2 |
| 6755854 | Gillick et al. | Jun 2004 | B2 |
| 6786922 | Schaeffer | Sep 2004 | B2 |
| 6790221 | Monroe et al. | Sep 2004 | B2 |
| 6790227 | Burgermeister | Sep 2004 | B2 |
| 6810882 | Langberg et al. | Nov 2004 | B2 |
| 6814752 | Chuter | Nov 2004 | B1 |
| 6827731 | Armstrong et al. | Dec 2004 | B2 |
| 6843400 | Lee | Jan 2005 | B1 |
| 6846323 | Yip et al. | Jan 2005 | B2 |
| 6849087 | Chuter | Feb 2005 | B1 |
| 6863685 | Davila et al. | Mar 2005 | B2 |
| 6866669 | Buzzard et al. | Mar 2005 | B2 |
| 6896697 | Yip et al. | May 2005 | B1 |
| 6899718 | Gifford, III et al. | May 2005 | B2 |
| 6899914 | Schaldach et al. | May 2005 | B2 |
| 6911039 | Shiu et al. | Jun 2005 | B2 |
| 6913600 | Valley et al. | Jul 2005 | B2 |
| 6942680 | Grayzel et al. | Sep 2005 | B2 |
| 6942689 | Majercak | Sep 2005 | B2 |
| 6945992 | Goodson, IV et al. | Sep 2005 | B2 |
| 6951554 | Johansen et al. | Oct 2005 | B2 |
| 6986784 | Weiser et al. | Jan 2006 | B1 |
| 6989021 | Bosma et al. | Jan 2006 | B2 |
| 7001422 | Escamilla et al. | Feb 2006 | B2 |
| 7001424 | Patel et al. | Feb 2006 | B2 |
| 7007698 | Thornton | Mar 2006 | B2 |
| 7018402 | Vito et al. | Mar 2006 | B2 |
| 7025791 | Levine et al. | Apr 2006 | B2 |
| 7037330 | Rivelli, Jr. et al. | May 2006 | B1 |
| 7041130 | Santini, Jr. et al. | May 2006 | B2 |
| 7052511 | Weldon | May 2006 | B2 |
| 7087088 | Berg et al. | Aug 2006 | B2 |
| 7105016 | Shiu et al. | Sep 2006 | B2 |
| 7122043 | Greenhalgh et al. | Oct 2006 | B2 |
| 7137993 | Acosta et al. | Nov 2006 | B2 |
| 7147655 | Chermoni | Dec 2006 | B2 |
| 7147656 | Andreas et al. | Dec 2006 | B2 |
| 7147661 | Chobotov et al. | Dec 2006 | B2 |
| 7150745 | Stern et al. | Dec 2006 | B2 |
| 7160312 | Saadat | Jan 2007 | B2 |
| 7163552 | Diaz | Jan 2007 | B2 |
| 7166125 | Baker et al. | Jan 2007 | B1 |
| 7169158 | Sniffin et al. | Jan 2007 | B2 |
| 7169163 | Becker | Jan 2007 | B2 |
| 7172617 | Colgan et al. | Feb 2007 | B2 |
| 7175654 | Bonsignore et al. | Feb 2007 | B2 |
| 7179284 | Khosravi et al. | Feb 2007 | B2 |
| 7182779 | Acosta et al. | Feb 2007 | B2 |
| 7186237 | Meyer et al. | Mar 2007 | B2 |
| 7192440 | Andreas et al. | Mar 2007 | B2 |
| 7201770 | Johnson et al. | Apr 2007 | B2 |
| 7208002 | Shelso | Apr 2007 | B2 |
| 7211101 | Carley et al. | May 2007 | B2 |
| 7243408 | Vietmeier | Jul 2007 | B2 |
| 7258697 | Cox et al. | Aug 2007 | B1 |
| 7261731 | Patel et al. | Aug 2007 | B2 |
| 7267684 | Rolando et al. | Sep 2007 | B2 |
| 7270668 | Andreas et al. | Sep 2007 | B2 |
| 7270673 | Yee et al. | Sep 2007 | B2 |
| 7273492 | Cheng et al. | Sep 2007 | B2 |
| 7279007 | Nikolic et al. | Oct 2007 | B2 |
| 7294146 | Chew et al. | Nov 2007 | B2 |
| 7296577 | Lashinski et al. | Nov 2007 | B2 |
| 7300456 | Andreas et al. | Nov 2007 | B2 |
| 7303572 | Meisheimer et al. | Dec 2007 | B2 |
| 7303580 | Parker | Dec 2007 | B2 |
| 7306617 | Majercak | Dec 2007 | B2 |
| 7309341 | Ortiz et al. | Dec 2007 | B2 |
| 7309350 | Landreville et al. | Dec 2007 | B2 |
| 7309353 | Krivoruchko | Dec 2007 | B2 |
| 7316711 | Allen et al. | Jan 2008 | B2 |
| 7320702 | Hammersmark et al. | Jan 2008 | B2 |
| 7323006 | Andreas et al. | Jan 2008 | B2 |
| 7323007 | Sano | Jan 2008 | B2 |
| 7326203 | Papineau et al. | Feb 2008 | B2 |
| 7326236 | Andreas et al. | Feb 2008 | B2 |
| 7329279 | Haug et al. | Feb 2008 | B2 |
| 7331987 | Cox | Feb 2008 | B1 |
| 7331990 | Gianotti | Feb 2008 | B2 |
| 7331992 | Randall et al. | Feb 2008 | B2 |
| 7351255 | Andreas | Apr 2008 | B2 |
| 7399307 | Evans et al. | Jul 2008 | B2 |
| 7402168 | Sanderson et al. | Jul 2008 | B2 |
| 7419501 | Chiu et al. | Sep 2008 | B2 |
| 7431729 | Chanduszko | Oct 2008 | B2 |
| 7445631 | Salaheih et al. | Nov 2008 | B2 |
| 7476245 | Abbate | Jan 2009 | B2 |
| 7479158 | Gregorich | Jan 2009 | B2 |
| 7500986 | Lye et al. | Mar 2009 | B2 |
| 7510575 | Spenser et al. | Mar 2009 | B2 |
| 7524330 | Berreklouw | Apr 2009 | B2 |
| 7537607 | Gerberding | May 2009 | B2 |
| 7550001 | Dorn et al. | Jun 2009 | B2 |
| 7553324 | Andreas et al. | Jun 2009 | B2 |
| 7556647 | Drews et al. | Jul 2009 | B2 |
| 7578840 | Schaeffer | Aug 2009 | B2 |
| 7591848 | Allen | Sep 2009 | B2 |
| 7604662 | Cambronne et al. | Oct 2009 | B2 |
| 7611497 | Wollschlager | Nov 2009 | B2 |
| 7617007 | Williams et al. | Nov 2009 | B2 |
| 7618432 | Pedersen et al. | Nov 2009 | B2 |
| 7618447 | Case et al. | Nov 2009 | B2 |
| 7625398 | Clifford et al. | Dec 2009 | B2 |
| 7625399 | Case et al. | Dec 2009 | B2 |
| 7628803 | Pavcnik et al. | Dec 2009 | B2 |
| 7637935 | Pappas et al. | Dec 2009 | B2 |
| 7655033 | Fearnot et al. | Feb 2010 | B2 |
| 7655034 | Mitchell et al. | Feb 2010 | B2 |
| 7658759 | Case et al. | Feb 2010 | B2 |
| 7666216 | Hogendijk et al. | Feb 2010 | B2 |
| 7674282 | Wu et al. | Mar 2010 | B2 |
| 7686824 | Konstantino et al. | Mar 2010 | B2 |
| 7686843 | Moore | Mar 2010 | B2 |
| 7695507 | Rivelli, Jr. et al. | Apr 2010 | B2 |
| 7720521 | Chang et al. | May 2010 | B2 |
| 7736387 | Pollock et al. | Jun 2010 | B2 |
| 7758594 | Lamson et al. | Jul 2010 | B2 |
| 7758625 | Wu et al. | Jul 2010 | B2 |
| 7758627 | Richter | Jul 2010 | B2 |
| 7758632 | Hojeibane et al. | Jul 2010 | B2 |
| 7763063 | Arbefeuille et al. | Jul 2010 | B2 |
| 7780716 | Pappas et al. | Aug 2010 | B2 |
| 7794489 | Shumer et al. | Sep 2010 | B2 |
| 7799065 | Pappas | Sep 2010 | B2 |
| 7806918 | Nissl et al. | Oct 2010 | B2 |
| 7810223 | Hemerick et al. | Oct 2010 | B2 |
| 7828834 | Garbe | Nov 2010 | B2 |
| 7833262 | McGuckin, Jr. et al. | Nov 2010 | B2 |
| 7842080 | Chouinard | Nov 2010 | B2 |
| 7846194 | Hartley et al. | Dec 2010 | B2 |
| 7867267 | Sullivan et al. | Jan 2011 | B2 |
| 7871431 | Gurm et al. | Jan 2011 | B2 |
| 7883537 | Grayzel et al. | Feb 2011 | B2 |
| 7896911 | Schneider et al. | Mar 2011 | B2 |
| 7905913 | Chew et al. | Mar 2011 | B2 |
| 7918880 | Austin | Apr 2011 | B2 |
| 7922755 | Acosta et al. | Apr 2011 | B2 |
| 7933660 | Carr | Apr 2011 | B2 |
| 7938851 | Olson et al. | May 2011 | B2 |
| 7942920 | Majercak | May 2011 | B2 |
| 7955315 | Feinberg et al. | Jun 2011 | B2 |
| 7963987 | Melsheimer et al. | Jun 2011 | B2 |
| 7967855 | Furst et al. | Jun 2011 | B2 |
| 7971333 | Gale et al. | Jul 2011 | B2 |
| 7972373 | Contiliano et al. | Jul 2011 | B2 |
| 7981149 | Contiliano et al. | Jul 2011 | B2 |
| 7993383 | Hartley et al. | Aug 2011 | B2 |
| 8002725 | Hogendijk | Aug 2011 | B2 |
| 8016870 | Chew et al. | Sep 2011 | B2 |
| 8016872 | Parker | Sep 2011 | B2 |
| 8024851 | Barr et al. | Sep 2011 | B2 |
| 8034099 | Pellegrini | Oct 2011 | B2 |
| 8043354 | Greenberg et al. | Oct 2011 | B2 |
| 8043357 | Hartley | Oct 2011 | B2 |
| 8048151 | O'Brien et al. | Nov 2011 | B2 |
| 8052738 | Craven | Nov 2011 | B2 |
| 8057543 | O'Brien et al. | Nov 2011 | B2 |
| 8062344 | Dorn et al. | Nov 2011 | B2 |
| 8075607 | Melsheimer et al. | Dec 2011 | B2 |
| 8092468 | Hansen | Jan 2012 | B2 |
| 8100958 | Fischer et al. | Jan 2012 | B2 |
| 8127422 | Wu | Mar 2012 | B2 |
| 8128677 | Schneider et al. | Mar 2012 | B2 |
| 8157851 | Andreas | Apr 2012 | B2 |
| 8157857 | Case et al. | Apr 2012 | B2 |
| 8177831 | Andreas | May 2012 | B2 |
| 8221489 | Issenmann et al. | Jul 2012 | B2 |
| 8236044 | Robaina | Aug 2012 | B2 |
| 8236045 | Benichou et al. | Aug 2012 | B2 |
| 8292938 | Case | Oct 2012 | B2 |
| 8308790 | Arbefeuille et al. | Nov 2012 | B2 |
| 8317859 | Snow et al. | Nov 2012 | B2 |
| 8323243 | Schneider et al. | Dec 2012 | B2 |
| 8328864 | Niermann | Dec 2012 | B2 |
| 8353945 | Andreas et al. | Jan 2013 | B2 |
| 8366766 | Berreklouw | Feb 2013 | B2 |
| 8382813 | Shumer | Feb 2013 | B2 |
| 8394139 | Roeder et al. | Mar 2013 | B2 |
| 8403978 | Schlun et al. | Mar 2013 | B2 |
| 8409267 | Berez et al. | Apr 2013 | B2 |
| 8414636 | Nabulsi et al. | Apr 2013 | B2 |
| 8414637 | Chouinard | Apr 2013 | B2 |
| 8460357 | McGarry et al. | Jun 2013 | B2 |
| 8460368 | Taylor et al. | Jun 2013 | B2 |
| 8474460 | Barrett et al. | Jul 2013 | B2 |
| 8486128 | Jen et al. | Jul 2013 | B2 |
| 8486132 | Snow et al. | Jul 2013 | B2 |
| 8496698 | Abunassar | Jul 2013 | B2 |
| 8500787 | Simpson et al. | Aug 2013 | B2 |
| 8500789 | Wuebbeling et al. | Aug 2013 | B2 |
| 8523935 | Fliedner | Sep 2013 | B2 |
| 8540760 | Paul, Jr. et al. | Sep 2013 | B2 |
| 8585747 | Andreas et al. | Nov 2013 | B2 |
| 8636793 | Hoerstrup et al. | Jan 2014 | B2 |
| 8641755 | Davis et al. | Feb 2014 | B2 |
| 8652198 | Andreas et al. | Feb 2014 | B2 |
| 8663310 | Greenberg et al. | Mar 2014 | B2 |
| 8667838 | Hoem et al. | Mar 2014 | B2 |
| 8734502 | Orr | May 2014 | B2 |
| 8740973 | Furst et al. | Jun 2014 | B2 |
| 8745842 | Wu | Jun 2014 | B2 |
| 8771335 | Griego et al. | Jul 2014 | B2 |
| 8778010 | Venturelli et al. | Jul 2014 | B2 |
| 8784467 | Connelly et al. | Jul 2014 | B2 |
| 8784468 | Gerdts et al. | Jul 2014 | B2 |
| 8821563 | Orr et al. | Sep 2014 | B2 |
| 8834556 | Papp et al. | Sep 2014 | B2 |
| 8864811 | Kao | Oct 2014 | B2 |
| 8888834 | Hansen et al. | Nov 2014 | B2 |
| 8888841 | Pandelidis et al. | Nov 2014 | B2 |
| 8900289 | Thompson | Dec 2014 | B2 |
| 8911487 | Bennett et al. | Dec 2014 | B2 |
| 8926689 | Bogert | Jan 2015 | B2 |
| 8956398 | George et al. | Feb 2015 | B2 |
| 8961583 | Hojeibane et al. | Feb 2015 | B2 |
| 8966736 | Wu | Mar 2015 | B2 |
| 8968383 | Johnson et al. | Mar 2015 | B1 |
| 8986362 | Snow et al. | Mar 2015 | B2 |
| 9005265 | Lootz et al. | Apr 2015 | B2 |
| 9005274 | Seguin et al. | Apr 2015 | B2 |
| 9023095 | Bueche et al. | May 2015 | B2 |
| 9050181 | Hartley | Jun 2015 | B2 |
| 9056351 | Krivoruchko et al. | Jun 2015 | B2 |
| 9095461 | Schaeffer | Aug 2015 | B2 |
| 9101500 | Feld et al. | Aug 2015 | B2 |
| 9101503 | Lowe et al. | Aug 2015 | B2 |
| 9101506 | Arbefeuille et al. | Aug 2015 | B2 |
| 9113999 | Taylor et al. | Aug 2015 | B2 |
| 9119717 | Wang et al. | Sep 2015 | B2 |
| 9125765 | Melsheimer | Sep 2015 | B2 |
| 9149379 | Keady et al. | Oct 2015 | B2 |
| 9192492 | Seguin et al. | Nov 2015 | B2 |
| 9192496 | Robinson | Nov 2015 | B2 |
| 9192500 | Longo et al. | Nov 2015 | B1 |
| 9198783 | Douk et al. | Dec 2015 | B2 |
| 9216082 | Von Segesser et al. | Dec 2015 | B2 |
| 9237959 | Cage | Jan 2016 | B2 |
| 9241702 | Maisano et al. | Jan 2016 | B2 |
| 9295571 | Newell et al. | Mar 2016 | B2 |
| 9301864 | Kao | Apr 2016 | B2 |
| 9314327 | Orr | Apr 2016 | B2 |
| 9314360 | Kao | Apr 2016 | B2 |
| 9339404 | Snow et al. | May 2016 | B2 |
| 9345597 | Pacetti | May 2016 | B2 |
| 9364350 | Pacetti et al. | Jun 2016 | B2 |
| 9370437 | Chuter et al. | Jun 2016 | B2 |
| 9375327 | Giasolli et al. | Jun 2016 | B2 |
| 9375336 | Longo et al. | Jun 2016 | B1 |
| 9398967 | Cornelius | Jul 2016 | B2 |
| 9408731 | Hartley et al. | Aug 2016 | B2 |
| 9421115 | Wübbeling et al. | Aug 2016 | B2 |
| 9427340 | Yadin | Aug 2016 | B2 |
| 9433520 | Longo | Sep 2016 | B2 |
| 9439795 | Wang et al. | Sep 2016 | B2 |
| 9445929 | Longo et al. | Sep 2016 | B2 |
| 9452067 | Wu | Sep 2016 | B2 |
| 9480826 | Schneider et al. | Nov 2016 | B2 |
| 9498296 | Hingston et al. | Nov 2016 | B2 |
| 9498322 | Thomas | Nov 2016 | B2 |
| 9539130 | Farag et al. | Jan 2017 | B2 |
| 9545322 | Schneider et al. | Jan 2017 | B2 |
| 9566179 | Andreas et al. | Feb 2017 | B2 |
| 9585777 | Pacetti | Mar 2017 | B2 |
| 9597213 | Green | Mar 2017 | B2 |
| 9603696 | Hartley et al. | Mar 2017 | B2 |
| 9603730 | Giasolli et al. | Mar 2017 | B2 |
| 9603980 | Zhao | Mar 2017 | B2 |
| 9662231 | Ngo et al. | May 2017 | B2 |
| 9668892 | Shalev et al. | Jun 2017 | B2 |
| 9700448 | Snow et al. | Jul 2017 | B2 |
| 9707115 | Masakazu | Jul 2017 | B2 |
| 9724224 | Gillick et al. | Aug 2017 | B2 |
| 9730818 | Giasolli et al. | Aug 2017 | B2 |
| 9737368 | Lumauig | Aug 2017 | B2 |
| 9867699 | Straubinger et al. | Jan 2018 | B2 |
| 9877828 | Straubinger et al. | Jan 2018 | B2 |
| 9895243 | Kariniemi et al. | Feb 2018 | B2 |
| 9908297 | Pacetti et al. | Mar 2018 | B2 |
| 9918835 | Guyenot et al. | Mar 2018 | B2 |
| 9931193 | Cully et al. | Apr 2018 | B2 |
| 9943428 | Burkart et al. | Apr 2018 | B2 |
| 9974670 | Schneider et al. | May 2018 | B2 |
| 9987154 | Pacetti et al. | Jun 2018 | B2 |
| 10016292 | Senness et al. | Jul 2018 | B2 |
| 10022250 | Giasolli et al. | Jul 2018 | B2 |
| 10098764 | Pacetti | Oct 2018 | B2 |
| 10111741 | Michalak | Oct 2018 | B2 |
| 10117762 | Giasolli et al. | Nov 2018 | B2 |
| 10137013 | Giasolli et al. | Nov 2018 | B2 |
| 10166127 | Giasolli et al. | Jan 2019 | B2 |
| 10188533 | Schneider et al. | Jan 2019 | B2 |
| 10231853 | Weber | Mar 2019 | B2 |
| 10231854 | Wack | Mar 2019 | B2 |
| 10238339 | Dlugach et al. | Mar 2019 | B2 |
| 10245167 | Longo | Apr 2019 | B2 |
| 10245168 | Amendt et al. | Apr 2019 | B2 |
| 10271970 | Paul et al. | Apr 2019 | B2 |
| 10271973 | Giasolli et al. | Apr 2019 | B2 |
| 10278839 | Giasolli et al. | May 2019 | B2 |
| 10285831 | Giasolli et al. | May 2019 | B2 |
| 10292845 | Higashi et al. | May 2019 | B2 |
| 10299945 | Schneider et al. | May 2019 | B2 |
| 10390977 | Giasolli et al. | Aug 2019 | B2 |
| 10406009 | Pacetti | Sep 2019 | B2 |
| 10470774 | Strauss et al. | Nov 2019 | B2 |
| 10485649 | Barthold et al. | Nov 2019 | B2 |
| 10624733 | Gonzalez et al. | Apr 2020 | B2 |
| 10660771 | Giasolli et al. | May 2020 | B2 |
| 10702679 | Chanduszko et al. | Jul 2020 | B2 |
| 10758381 | Longo et al. | Sep 2020 | B2 |
| 10779968 | Giasolli et al. | Sep 2020 | B2 |
| 10779969 | Giasolli et al. | Sep 2020 | B2 |
| 10779971 | Giasolli et al. | Sep 2020 | B2 |
| 10799374 | Schneider et al. | Oct 2020 | B2 |
| 10835395 | Schneider et al. | Nov 2020 | B2 |
| 20020120323 | Thompson | Aug 2002 | A1 |
| 20020123790 | White et al. | Sep 2002 | A1 |
| 20020165599 | Nasralla | Nov 2002 | A1 |
| 20020169495 | Gifford et al. | Nov 2002 | A1 |
| 20030055480 | Fischell et al. | Mar 2003 | A1 |
| 20030055491 | Schwartz et al. | Mar 2003 | A1 |
| 20030069630 | Burgermeister et al. | Apr 2003 | A1 |
| 20030074049 | Hoganson et al. | Apr 2003 | A1 |
| 20030130720 | DePalma et al. | Jul 2003 | A1 |
| 20030220683 | Minasian et al. | Nov 2003 | A1 |
| 20030225446 | Hartley | Dec 2003 | A1 |
| 20030225448 | Gerberding | Dec 2003 | A1 |
| 20040010307 | Grad et al. | Jan 2004 | A1 |
| 20040186551 | Kao et al. | Sep 2004 | A1 |
| 20040186558 | Pavcnik et al. | Sep 2004 | A1 |
| 20040215229 | Coyle | Oct 2004 | A1 |
| 20040215324 | Vonderwalde et al. | Oct 2004 | A1 |
| 20040260389 | Case et al. | Dec 2004 | A1 |
| 20040267281 | Harari et al. | Dec 2004 | A1 |
| 20040267348 | Gunderson et al. | Dec 2004 | A1 |
| 20050010275 | Sahatjian et al. | Jan 2005 | A1 |
| 20050021123 | Dorn et al. | Jan 2005 | A1 |
| 20050096731 | Looi et al. | May 2005 | A1 |
| 20050149163 | Sahota | Jul 2005 | A1 |
| 20050246008 | Hogendijk et al. | Nov 2005 | A1 |
| 20050251164 | Gifford, III et al. | Nov 2005 | A1 |
| 20050273151 | Fulkerson | Dec 2005 | A1 |
| 20050278011 | Peckham | Dec 2005 | A1 |
| 20050288764 | Snow et al. | Dec 2005 | A1 |
| 20050288766 | Plain et al. | Dec 2005 | A1 |
| 20060047297 | Case | Mar 2006 | A1 |
| 20060069424 | Acosta et al. | Mar 2006 | A1 |
| 20060074478 | Feller, III | Apr 2006 | A1 |
| 20060111769 | Murray | May 2006 | A1 |
| 20060184225 | Pryor | Aug 2006 | A1 |
| 20060184226 | Austin | Aug 2006 | A1 |
| 20060184227 | Rust | Aug 2006 | A1 |
| 20060206190 | Chermoni | Sep 2006 | A1 |
| 20060248698 | Hanson et al. | Nov 2006 | A1 |
| 20060265040 | Murray | Nov 2006 | A1 |
| 20060282149 | Kao | Dec 2006 | A1 |
| 20060282150 | Olson et al. | Dec 2006 | A1 |
| 20070088420 | Andreas et al. | Apr 2007 | A1 |
| 20070093744 | Elmaleh | Apr 2007 | A1 |
| 20070142892 | Dave et al. | Jun 2007 | A1 |
| 20070156223 | Vaughan | Jul 2007 | A1 |
| 20070156224 | Cioanta et al. | Jul 2007 | A1 |
| 20070156225 | George et al. | Jul 2007 | A1 |
| 20070156226 | Chew et al. | Jul 2007 | A1 |
| 20070179587 | Acosta et al. | Aug 2007 | A1 |
| 20070191926 | Nikanorov et al. | Aug 2007 | A1 |
| 20080033522 | Grewe et al. | Feb 2008 | A1 |
| 20080051867 | Davila et al. | Feb 2008 | A1 |
| 20080077229 | Andres et al. | Mar 2008 | A1 |
| 20080082154 | Tseng et al. | Apr 2008 | A1 |
| 20080132999 | Mericle et al. | Jun 2008 | A1 |
| 20080188207 | Lee | Aug 2008 | A1 |
| 20080208327 | Rowe | Aug 2008 | A1 |
| 20080221658 | Martin et al. | Sep 2008 | A1 |
| 20080255653 | Schkolnik | Oct 2008 | A1 |
| 20080264102 | Berra | Oct 2008 | A1 |
| 20080269865 | Snow et al. | Oct 2008 | A1 |
| 20080319528 | Yribarren et al. | Dec 2008 | A1 |
| 20090048654 | Chmura et al. | Feb 2009 | A1 |
| 20090069878 | Weber et al. | Mar 2009 | A1 |
| 20090076594 | Sabaria | Mar 2009 | A1 |
| 20090082841 | Zacharias et al. | Mar 2009 | A1 |
| 20090099641 | Wu et al. | Apr 2009 | A1 |
| 20090149943 | Tower | Jun 2009 | A1 |
| 20090216284 | Chin et al. | Aug 2009 | A1 |
| 20090228093 | Taylor | Sep 2009 | A1 |
| 20090248139 | Pellegrini | Oct 2009 | A1 |
| 20090248141 | Shandas et al. | Oct 2009 | A1 |
| 20090270965 | Sinha et al. | Oct 2009 | A1 |
| 20090270967 | Fleming, III et al. | Oct 2009 | A1 |
| 20090276031 | Kao | Nov 2009 | A1 |
| 20100131045 | Globerman et al. | May 2010 | A1 |
| 20100137966 | Magnuson | Jun 2010 | A1 |
| 20100145431 | Wu et al. | Jun 2010 | A1 |
| 20100228333 | Drasler et al. | Sep 2010 | A1 |
| 20100318173 | Kolandaivelu et al. | Dec 2010 | A1 |
| 20110004237 | Schneider et al. | Jan 2011 | A1 |
| 20110077731 | Lee et al. | Mar 2011 | A1 |
| 20110082490 | Connelly | Apr 2011 | A1 |
| 20110190864 | McClain et al. | Aug 2011 | A1 |
| 20110230954 | Schneider et al. | Sep 2011 | A1 |
| 20120016457 | Chobotov et al. | Jan 2012 | A1 |
| 20120035705 | Giasolli et al. | Feb 2012 | A1 |
| 20120041469 | Fischell et al. | Feb 2012 | A1 |
| 20120065722 | Pacetti | Mar 2012 | A1 |
| 20120172963 | Ryan et al. | Jul 2012 | A1 |
| 20120191176 | Nagl et al. | Jul 2012 | A1 |
| 20120226343 | Vo et al. | Sep 2012 | A1 |
| 20120283811 | Neilan | Nov 2012 | A1 |
| 20130138202 | Paul et al. | May 2013 | A1 |
| 20140088565 | Vongphakdy et al. | Mar 2014 | A1 |
| 20140094929 | Shin et al. | Apr 2014 | A1 |
| 20140107761 | Gale et al. | Apr 2014 | A1 |
| 20140194967 | Schneider et al. | Jul 2014 | A1 |
| 20140214068 | Zhu et al. | Jul 2014 | A1 |
| 20140288629 | Amendt | Sep 2014 | A1 |
| 20150297378 | Senness et al. | Oct 2015 | A1 |
| 20160192942 | Strauss et al. | Jul 2016 | A1 |
| 20160242943 | Riedy et al. | Aug 2016 | A1 |
| 20160374839 | Longo et al. | Dec 2016 | A1 |
| 20170000629 | Giasolli et al. | Jan 2017 | A1 |
| 20170000633 | Longo | Jan 2017 | A1 |
| 20170181873 | Schneider et al. | Jun 2017 | A1 |
| 20170231751 | Barthold et al. | Aug 2017 | A1 |
| 20170281375 | Longo et al. | Oct 2017 | A1 |
| 20170296366 | Giasolli et al. | Oct 2017 | A1 |
| 20170319361 | Giasolli et al. | Nov 2017 | A1 |
| 20170319364 | Jung et al. | Nov 2017 | A1 |
| 20170367856 | Tanaka et al. | Dec 2017 | A1 |
| 20180000619 | Longo et al. | Jan 2018 | A1 |
| 20180028306 | Gonzalez et al. | Feb 2018 | A1 |
| 20180110634 | Giasolli et al. | Apr 2018 | A1 |
| 20180154123 | Werneth et al. | Jun 2018 | A1 |
| 20180272044 | Hossainy et al. | Sep 2018 | A1 |
| 20180318116 | Eli et al. | Nov 2018 | A1 |
| 20190069985 | Nennig et al. | Mar 2019 | A1 |
| 20190070025 | Fu et al. | Mar 2019 | A1 |
| 20190192319 | Giasolli et al. | Jun 2019 | A1 |
| 20190192321 | Schneider et al. | Jun 2019 | A1 |
| 20190282381 | Giasolli et al. | Sep 2019 | A1 |
| 20190298555 | Longo | Oct 2019 | A1 |
| 20200155332 | Longo et al. | May 2020 | A1 |
| 20200352753 | Giasolli et al. | Nov 2020 | A1 |
| Number | Date | Country |
|---|---|---|
| 2008335140 | Nov 2012 | AU |
| 2011274392 | Nov 2013 | AU |
| 2014201067 | Mar 2014 | AU |
| 2010259907 | Aug 2015 | AU |
| 2013212056 | Jul 2016 | AU |
| 2015207895 | May 2017 | AU |
| 2014280976 | Jul 2017 | AU |
| 2705275 | Jul 2013 | CA |
| 1856280 | Nov 2006 | CN |
| 101102728 | Jan 2008 | CN |
| 101262835 | Sep 2008 | CN |
| 101754727 | Jun 2010 | CN |
| 101909552 | Dec 2010 | CN |
| 102164565 | Aug 2011 | CN |
| 102292036 | Dec 2011 | CN |
| 102573701 | Jul 2012 | CN |
| 102724931 | Oct 2012 | CN |
| 104042380 | Sep 2014 | CN |
| 103313682 | Aug 2016 | CN |
| 104220026 | Sep 2016 | CN |
| 106466205 | Mar 2017 | CN |
| 106473786 | Mar 2017 | CN |
| 106473849 | Mar 2017 | CN |
| 107028691 | Aug 2017 | CN |
| 107157632 | Sep 2017 | CN |
| 107205834 | Sep 2017 | CN |
| 107405208 | Nov 2017 | CN |
| 104887365 | Dec 2017 | CN |
| 107427375 | Dec 2017 | CN |
| 60030705 | May 2007 | DE |
| 10 2009 041 025 | Mar 2011 | DE |
| 20 2011 107 781 | Dec 2011 | DE |
| 20 2011 110 714 | Dec 2015 | DE |
| 10 2014 016 588 | May 2016 | DE |
| 20 2011 110 818 | Sep 2016 | DE |
| 2775968 | Dec 2017 | DK |
| 0497620 | Aug 1992 | EP |
| 0714640 | Jun 1996 | EP |
| 0855883 | Aug 1998 | EP |
| 0812580 | Feb 2004 | EP |
| 1393766 | Mar 2004 | EP |
| 1236446 | Aug 2005 | EP |
| 1787593 | May 2007 | EP |
| 1803423 | Jul 2007 | EP |
| 1894545 | Mar 2008 | EP |
| 1452151 | Oct 2008 | EP |
| 1567093 | Jan 2009 | EP |
| 1378212 | Sep 2009 | EP |
| 2219535 | Aug 2010 | EP |
| 0732088 | Dec 2011 | EP |
| 2440155 | Apr 2012 | EP |
| 1729682 | Apr 2013 | EP |
| 1786367 | Apr 2013 | EP |
| 1973502 | Apr 2014 | EP |
| 2806826 | Dec 2014 | EP |
| 2881086 | Jun 2015 | EP |
| 2699207 | Oct 2015 | EP |
| 2590602 | Dec 2015 | EP |
| 3015078 | May 2016 | EP |
| 3058900 | Aug 2016 | EP |
| 1689327 | Sep 2016 | EP |
| 3072463 | Sep 2016 | EP |
| 3187222 | Jul 2017 | EP |
| 2775968 | Sep 2017 | EP |
| 3217927 | Sep 2017 | EP |
| 2967830 | Nov 2017 | EP |
| 3250159 | Dec 2017 | EP |
| 3421010 | Jan 2019 | EP |
| 2714816 | Jul 1995 | FR |
| 201106757 | Jun 2011 | GB |
| H06-000221 | Jan 1994 | JP |
| H08-332229 | Dec 1996 | JP |
| H11-501526 | Feb 1999 | JP |
| H11-506665 | Jun 1999 | JP |
| 2002-513298 | May 2002 | JP |
| 2007-503923 | Mar 2007 | JP |
| 2007-504897 | Mar 2007 | JP |
| 2007-508112 | Apr 2007 | JP |
| 2008-504078 | Feb 2008 | JP |
| 2008-507376 | Mar 2008 | JP |
| 2008-510587 | Apr 2008 | JP |
| 2008-246214 | Oct 2008 | JP |
| 2008-537891 | Oct 2008 | JP |
| 2009-532115 | Sep 2009 | JP |
| 2010-516333 | May 2010 | JP |
| 2012-523922 | Oct 2012 | JP |
| 2016-135278 | Jul 2016 | JP |
| 2016-147051 | Aug 2016 | JP |
| 6006808 | Oct 2016 | JP |
| 10-2017-0084214 | Jul 2017 | KR |
| WO 1996002211 | Feb 1996 | WO |
| WO 1996009013 | Mar 1996 | WO |
| WO 1996037167 | Nov 1996 | WO |
| WO 1998007390 | Feb 1998 | WO |
| WO 1999048440 | Sep 1999 | WO |
| WO 1999049440 | Sep 1999 | WO |
| WO 2000027310 | May 2000 | WO |
| WO 2000066034 | Nov 2000 | WO |
| WO 2001076509 | Oct 2001 | WO |
| WO 2002034163 | May 2002 | WO |
| WO 2003047651 | Jun 2003 | WO |
| WO 2003101310 | Dec 2003 | WO |
| WO 2004006983 | Jan 2004 | WO |
| WO 2004032799 | Apr 2004 | WO |
| WO 2004091441 | Oct 2004 | WO |
| WO 2005039449 | May 2005 | WO |
| WO 2006005082 | Jan 2006 | WO |
| WO 2006014767 | Feb 2006 | WO |
| WO 2006026371 | Mar 2006 | WO |
| WO 2006026377 | Mar 2006 | WO |
| WO 2006110258 | Oct 2006 | WO |
| WO 2007088549 | Aug 2007 | WO |
| WO 2007109621 | Sep 2007 | WO |
| WO 2007118005 | Oct 2007 | WO |
| WO 2009076517 | Jun 2009 | WO |
| WO 2010037141 | Apr 2010 | WO |
| WO 2010044874 | Apr 2010 | WO |
| WO 2010118432 | Oct 2010 | WO |
| WO 2010144845 | Dec 2010 | WO |
| WO 2011153110 | Dec 2011 | WO |
| WO 2012006602 | Jan 2012 | WO |
| WO 2012143731 | Oct 2012 | WO |
| WO 2013068127 | May 2013 | WO |
| WO 2013112768 | Aug 2013 | WO |
| WO 2013118362 | Aug 2013 | WO |
| WO 2016074799 | May 2016 | WO |
| WO 2016122947 | Aug 2016 | WO |
| WO 2017117391 | Jul 2017 | WO |
| WO 2018175048 | Sep 2018 | WO |
| WO 2019023258 | Jan 2019 | WO |
| Entry |
|---|
| U.S. Appl. No. 15/375,026, filed Dec. 9, 2016, Device and Method for Tacking Plaque to Blood Vessel Wall. |
| U.S. Appl. No. 14/102,411, filed Dec. 10, 2013, Method of Treating Atherosclerotic Occlusive Disease. |
| U.S. Appl. No. 15/640,095, filed Jun. 30, 2017, Endovascular Implant. |
| U.S. Appl. No. 16/426,627, filed May 30, 2019, Endovascular Implant and Deployment Devices. |
| U.S. Appl. No. 16/225,528, filed Dec. 19, 2018, Endoluminal Device and Method. |
| Bosiers, M. et al., “Results from the Tack Optimized Balloon Angioplasty (TOBA) study demonstrate the benefits of minimal metal implants for dissection repair after angioplasty”, Journal of Vascular Surgery, vol. 64, Jul. 2016, in 8 pages. |
| Colombo, A. et al., “Intravascular Ultrasound-Guided Percutaneous Transluminal Coronary Angioplasty With Provisional Spot Stenting for Treatment of Long Coronary Lesions”, Journal of the American College of Cardiology, vol. 38, No. 5, Nov. 1, 2001, in 9 pages. |
| Kokkinidis, D. et al., “Emerging and Future Therapeutic Options for Femoropopliteal and Infrapopliteal Endovascular Intervention”, Interventional Cardiology Clinics, vol. 6, 2017, in 17 pages. |
| Mosseri, M. et al., “New Indicator for Stent Covering Area”, in Catheterization and Cardiovascular Diagnosis, 1998, vol. 44, in 5 pages. |
| Shishehbor, M. et al., “Endovascular Treatment of Femoropopliteal Lesions”, Journal of the American College of Cardiology, vol. 66, 2015, in 4 pages. |
| Zeller, T. et al., “Novel Approaches to the Management of Advanced Peripheral Artery Disease: Perspectives on Drug-Coated Balloons, Drug-Eluting Stents, and Bioresorbable Scaffolds”, Current Cardiology Reports, vol. 17, Sep. 2015, in 6 pages. |
| International Search Report and Written Opinion, re PCT Application No. PCT/US2010/038379, dated Feb. 25, 2011. |
| International Search Report and Written Opinion, re PCT Application No. PCT/US2011/038468, dated Jan. 18, 2012. |
| International Search Report and Written Opinion, re PCT Application No. PCT/US2013/023030, dated Apr. 16, 2013. |
| International Search Report and Written Opinion, re PCT Application No. PCT/US2016/014161, dated Apr. 12, 2016. |
| International Search Report and Written Opinion, re PCT Application PCT/US2008/086396, dated Jul. 27, 2009. |
| International Search Report and Written Opinion, re PCT Application PCT/US2011/043471, dated Feb. 9, 2012. |
| International Search Report and Written Opinion, re PCT Application No. PCT/US2016/069211, dated Mar. 27, 2017. |
| International Search Report and Written Opinion, re PCT Application No. PCT/US2018/043528, dated Sep. 26, 2018. |
| U.S. Appl. No. 11/955,331 (U.S. Pat. No. 7,896,911), filed Dec. 12, 2007 (Mar. 1, 2011), Device and Method for Tacking Plaque to Blood Vessel Wall. |
| U.S. Appl. No. 13/038,175 (U.S. Pat. No. 9,545,322), filed Mar. 1, 2011 (Jan. 17, 2017), Device and Method for Tacking Plaque to Blood Vessel Wall. |
| U.S. Appl. No. 15/375,026 (U.S. Pat. No. 10,799,374), filed Dec. 9, 2016 (Oct. 13, 2020), Device and Method for Tacking Plaque to Blood Vessel Wall. |
| U.S. Appl. No. 16/998,168, filed Aug. 20, 2020, Device and Method for Tacking Plaque to Blood Vessel Wall. |
| U.S. Appl. No. 12/483,193 (U.S. Pat. No. 8,128,677), filed Jun. 11, 2009 (Mar. 6, 2012), Device and Method for Tacking Plaque to a Blood Vessel Wall. |
| U.S. Appl. No. 13/246,776 (U.S. Pat. No. 9,974,670), filed Sep. 27, 2011 (May 22, 2018), Method of Treating Atherosclerotic Occlusive Disease. |
| U.S. Appl. No. 15/984,111 (U.S. Pat. No. 10,299,945), filed May 18, 2018 (May 28, 2019), Method of Treating Atherosclerotic Occlusive Disease. |
| U.S. Appl. No. 14/102,411 (U.S. Pat. No. 10,835,395), filed Dec. 10, 2013 (Nov. 17, 2020), Method of Treating Atherosclerotic Occlusive Disease. |
| U.S. Appl. No. 17/065,777, filed Oct. 8, 2020, Method of Treating Atherosclerotic Occlusive Disease. |
| U.S. Appl. No. 12/790,819 (U.S. Pat. No. 10,188,533), filed May 29, 2010 (Jan. 29, 2019), Minimal Surface Area Contact Device for Holding Plaque to Blood Vessel Wall. |
| U.S. Appl. No. 16/259,146, filed Jan. 28, 2019, Minimal Surface Area Contact Device for Holding Plaque to Blood Vessel Wall. |
| U.S. Appl. No. 13/118,388, filed May 28, 2011, Stent Device Having Focal Elevating Elements for Minimal Surface Area Contact with Lumen Walls. |
| U.S. Appl. No. 13/179,458 (U.S. Pat. No. 10,022,250), filed Jul. 8, 2011 (Jul. 17, 2018), Deployment Device for Placement of Multiple Intraluminal Surgical Staples. |
| U.S. Appl. No. 15/815,515, filed Nov. 16, 2017, Deployment Device for Placement of Multiple Intraluminal Surgical Staples. |
| U.S. Appl. No. 15/921,464 (U.S. Pat. No. 10,660,771), filed Mar. 14, 2018 (May 26, 2020), Deployment Device for Placement of Multiple Intraluminal Surgical Staples. |
| U.S. Appl. No. 16/881,385, filed May 22, 2020, Deployment Device for Placement of Multiple Intraluminal Surgical Staples. |
| U.S. Appl. No. 13/153,257 (U.S. Pat. No. 9,375,327), filed Jun. 3, 2011 (Jun. 28, 2016), Endovascular Implant. |
| U.S. Appl. No. 15/170,772 (U.S. Pat. No. 10,278,839), filed Jun. 1, 2016 (May 7, 2019), Endovascular Implant. |
| U.S. Appl. No. 15/640,095 (U.S. Pat. No. 10,779,971), filed Jun. 30, 2017 (Sep. 22, 2020), Endovascular Implant. |
| U.S. Appl. No. 15/921,448 (U.S. Pat. No. 10,285,831), filed Mar. 14, 2018 (May 14, 2019), Endovascular Implant. |
| U.S. Appl. No. 15/921,459 (U.S. Pat. No. 10,390,977), filed Mar. 14, 2018 (Aug. 27, 2019), Endovascular Implant. |
| U.S. Appl. No. 15/921,477 (U.S. Pat. No. 10,271,973), filed Mar. 14, 2018 (Apr. 30, 2019), Endovascular Implant. |
| U.S. Appl. No. 16/426,627 (U.S. Pat. No. 10,779,969), May 30, 2019 (Sep. 22, 2020), Endovascular Implant and Deployment Devices. |
| U.S. Appl. No. 16/998,190, filed Aug. 20, 2020, Endovascular Implant. |
| U.S. Appl. No. 13/749,643 (U.S. Pat. No. 9,730,818), filed Jan. 24, 2013 (Aug. 15, 2017), Endoluminal Device and Method. |
| U.S. Appl. No. 14/089,703 (U.S. Pat. No. 9,603,730), filed Nov. 25, 2013 (Mar. 28, 2017), Endoluminal Device and Method. |
| U.S. Appl. No. 15/472,215, filed Mar. 28, 2017, Endoluminal Device and Method. |
| U.S. Appl. No. 15/654,586 (U.S. Pat. No. 10,117,762), filed Jul. 19, 2017 (Nov. 6, 2018), Endoluminal Device and Method. |
| U.S. Appl. No. 15/837,870 (U.S. Pat. No. 10,137,013), filed Dec. 11, 2017 (Nov. 27, 2018), Endoluminal Device and Method. |
| U.S. Appl. No. 15/921,541 (U.S. Pat. No. 10,166,127), filed Mar. 14, 2018 (Jan. 1, 2019), Endoluminal Device and Method. |
| U.S. Appl. No. 16/225,528 (U.S. Pat. No. 10,779,968), filed Dec. 19, 2018 (Sep. 22, 2020), Endoluminal Device and Method. |
| U.S. Appl. No. 16/998,196, filed Aug. 20, 2020, Endoluminal Device and Method. |
| U.S. Appl. No. 13/939,019, filed Jul. 10, 2013, Systems and Methods for Attaching Radiopaque Markers to a Medical Device. |
| U.S. Appl. No. 14/746,636 (U.S. Pat. No. 9,192,500), filed Jun. 22, 2015 (Nov. 24, 2015), Delivery Device and Method of Delivery. |
| U.S. Appl. No. 14/885,295 (U.S. Pat. No. 9,375,337), filed Oct. 16, 2015 (Jun. 28, 2016), Delivery Device and Method of Delivery. |
| U.S. Appl. No. 15/133,709, filed Apr. 20, 2016, Delivery Device and Method of Delivery. |
| U.S. Appl. No. 14/935,087 (U.S. Pat. No. 9,345,603), filed Nov. 6, 2015 (May 24, 2016), Delivery Device and Method of Delivery. |
| U.S. Appl. No. 15/133,751 (U.S. Pat. No. 9,602,786), filed Apr. 20, 2016 (Mar. 21, 2017), Delivery Device and Method of Delivery. |
| U.S. Appl. No. 14/935,121 (U.S. Pat. No. 9,320,632), filed Nov. 6, 2015 (Apr. 26, 2016), Delivery Device and Method of Delivery. |
| U.S. Appl. No. 15/133,158 (U.S. Pat. No. 9,584,777), filed Apr. 19, 2016 (Feb. 28, 2017), Delivery Device and Method of Delivery. |
| U.S. Appl. No. 15/011,321 (U.S. Pat. No. 9,456,914), filed Jan. 29, 2016 (Oct. 4, 2016), Delivery Device and Method of Delivery. |
| U.S. Appl. No. 15/134,315 (U.S. Pat. No. 9,585,782), filed Apr. 20, 2016 (Mar. 7, 2017), Delivery Device and Method of Delivery. |
| U.S. Appl. No. 15/415,167 (U.S. Pat. No. 10,610,392), filed Jan. 25, 2017 (Apr. 7, 2020), Delivery Device and Method of Delivery. |
| U.S. Appl. No. 16/821,578, filed Mar. 17, 2020, Delivery Device and Method of Delivery. |
| U.S. Appl. No. 14/656,462 (U.S. Pat. No. 9,375,336), filed Mar. 12, 2015 (Jun. 28, 2016), Delivery Device and Method of Delivery. |
| U.S. Appl. No. 14/935,154 (U.S. Pat. No. 9,445,929), filed Nov. 6, 2015 (Sep. 20, 2016), Delivery Device and Method of Delivery. |
| U.S. Appl. No. 15/194,410, filed Jun. 27, 2016, Delivery Device and Method of Delivery. |
| U.S. Appl. No. 15/000,437 (U.S. Pat. No. 9,433,520), filed Jan. 19, 2016 (Sep. 6, 2016), Delivery Device and Method of Delivery. |
| U.S. Appl. No. 15/227,757 (U.S. Pat. No. 10,245,167), filed Aug. 3, 2016 (Apr. 2, 2019), Delivery Device and Method of Delivery. |
| U.S. Appl. No. 16/372,224, filed Apr. 1, 2019, Delivery Device and Method of Delivery. |
| U.S. Appl. No. 15/705,793, filed Sep. 15, 2017, Delivery Device and Method of Delivery. |
| U.S. Appl. No. 16/632,841, filed Jan. 21, 2020, Delivery Device and Method of Delivery. |
| Number | Date | Country | |
|---|---|---|---|
| 20190008667 A1 | Jan 2019 | US |
| Number | Date | Country | |
|---|---|---|---|
| 62369683 | Aug 2016 | US | |
| 62274236 | Jan 2016 | US |
| Number | Date | Country | |
|---|---|---|---|
| Parent | 15000437 | Jan 2016 | US |
| Child | 16067082 | US |
